Advanced Micro Devices (AMD) 10-K 5 Feb 25 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 28, 2024	Jan. 30, 2025	Jun. 28, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 28, 2024
Current Fiscal Year End Date	--12-28
Document Transition Report	false
Entity File Number	001-07882
Entity Registrant Name	ADVANCED MICRO DEVICES, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1692300
Entity Address, Address Line One	2485 Augustine Drive
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	749-4000
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	AMD
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 261.4
Entity Common Stock, Shares Outstanding		1,620,477,962
Documents Incorporated by Reference	Portions of the registrant’s proxy statement for the 2025 Annual Meeting of Stockholders (2025 Proxy Statement) are incorporated into Part III hereof. The 2025 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the registrant’s fiscal year ended December 28, 2024.
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Entity Central Index Key	0000002488
Auditor Firm ID	42
Document Financial Statement Error Correction [Flag]	false

Audit Information

Audit Information	12 Months Ended
	Dec. 28, 2024
Auditor [Line Items]
Auditor Location	San Jose, California
Auditor Name	Ernst & Young LLP
Auditor Firm ID	42

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net revenue	$ 25,785	$ 22,680	$ 23,601
Cost of sales	12,114	11,278	11,550
Cost, Depreciation, Amortization and Depletion	946	942	1,448
Total cost of sales	13,060	12,220	12,998
Gross profit	12,725	10,460	10,603
Research and development	6,456	5,872	5,005
Marketing, general and administrative	2,783	2,352	2,336
Amortization of acquisition-related intangibles_Opex	1,448	1,869	2,100
Restructuring charges	186	0	0
Licensing gain	(48)	(34)	(102)
Operating income	1,900	401	1,264
Interest expense	(92)	(106)	(88)
Other income (expense), net	181	197	8
Income before income taxes and equity income	1,989	492	1,184
Income tax provision (benefit)	381	(346)	(122)
Equity income in investee	33	16	14
Net income	$ 1,641	$ 854	$ 1,320
Earnings per share
Basic (in usd per share)	$ 1.01	$ 0.53	$ 0.85
Diluted (in usd per share)	$ 1	$ 0.53	$ 0.84
Shares used in per share calculation
Basic (in shares)	1,620	1,614	1,561
Diluted (in shares)	1,637	1,625	1,571

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Net income	$ 1,641	$ 854	$ 1,320
Net change in unrealized gains (losses) on cash flow hedges	(59)	31	(38)
Total comprehensive income	$ 1,582	$ 885	$ 1,282

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Current assets:
Cash and cash equivalents	$ 3,787	$ 3,933
Short-term investments	1,345	1,840
Accounts receivable, net	6,192	4,323
Inventories	5,734	4,351
Other Receivables	113	9
Prepaid expenses and other current assets	1,878	2,312
Total current assets	19,049	16,768
Property and equipment, net	1,802	1,589
Operating lease right-of-use assets	623	633
Goodwill	24,839	24,262
Acquisition-related intangibles	18,930	21,363
Investment: equity method	149	99
Deferred tax assets, net	688	366
Other non-current assets	3,146	2,805
Total assets	69,226	67,885
Current liabilities:
Accounts payable	1,990	2,055
Accounts Payable, Other	476	363
Accrued liabilities	4,260	3,082
Current portion of long-term debt, net	0	751
Other current liabilities	555	438
Total current liabilities	7,281	6,689
Long-term debt, net of current portion	1,721	1,717
Long-term operating lease liabilities	491	535
Deferred tax liabilities	349	1,202
Other long-term liabilities	1,816	1,850
Commitments and Contingencies (see Notes 17 and 18)
Stockholders’ equity:
Common Stock, Value, Issued	17	17
Additional paid-in capital	61,362	59,676
Treasury Stock, Value	(6,106)	(4,514)
Retained earnings	2,364	723
Accumulated other comprehensive loss	(69)	(10)
Total stockholders’ equity	57,568	55,892
Total liabilities and stockholders’ equity	$ 69,226	$ 67,885

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Millions	Dec. 28, 2024	Dec. 30, 2023
Statement of Financial Position [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	2,250	2,250
Common stock, shares issued (shares)	1,680	1,663
Common stock, shares outstanding (shares)	1,622	1,616
Treasury stock (shares)	58	47

Consolidated Statements of Stoc

Consolidated Statements of Stockholders Equity - USD ($) $ in Millions	Total	Common stock	Additional paid-in capital	Additional paid-in capital fair value of common stock issued as acquisition consideration	Additional paid-in capital pre-combination unvested restricted stock units assumed	Retained earnings (accumulated deficit)	Accumulated other comprehensive loss	Treasury stock
Beginning balance at Dec. 25, 2021		$ 12	$ 11,069			$ (1,451)	$ (3)	$ (2,130)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation			1,080
Issuance of common stock warrants			42
Issuance of common stock to settle convertible debt			0
Payment, Tax Withholding, Share-based Payment Arrangement	$ 406							(405)
Net income	1,320					1,320
Other comprehensive income (loss)							(38)
Ending balance at Dec. 31, 2022	54,750	16	58,005			(131)	(41)	(3,099)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Consideration transferred		4		$ 45,372	$ 275			3,138
Repurchases of common stock								(3,702)
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture		0	167
Stock-based compensation			1,384
Issuance of common stock warrants			13
Issuance of common stock to settle convertible debt			1
Payment, Tax Withholding, Share-based Payment Arrangement	427							(430)
Net income	854					854
Other comprehensive income (loss)							31
Ending balance at Dec. 30, 2023	55,892	17	59,676			723	(10)	(4,514)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Consideration transferred		0		0	0			0
Repurchases of common stock								(985)
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture		1	273
Stock-based compensation			1,407
Issuance of common stock warrants			0
Issuance of common stock to settle convertible debt			0
Payment, Tax Withholding, Share-based Payment Arrangement	728							(730)
Net income	1,641					1,641
Other comprehensive income (loss)							(59)
Ending balance at Dec. 28, 2024	57,568	17	61,362			$ 2,364	$ (69)	(6,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Consideration transferred		0		$ 0	$ 0			0
Repurchases of common stock	$ 862							$ (862)
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture		$ 0	$ 279

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 1,641	$ 854	$ 1,320
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	671	642	626
Amortization of operating lease right-of-use assets	2,393	2,811	3,548
Stock-based compensation	1,407	1,384	1,081
Amortization of operating lease right-of-use assets	113	98	88
Amortization of Inventory FV adjustment	0	3	189
Deferred income taxes	(1,163)	(1,019)	(1,505)
Inventory loss at contract manufacturer	65	0	0
Other	12	(57)	64
Changes in operating assets and liabilities:
Accounts receivable, net	(1,865)	(1,339)	(278)
Inventories	(1,458)	(580)	(1,401)
Prepaid expenses and other assets	343	(383)	(2,010)
Receivables from and payable to related parties, net	108	(107)	366
Accounts payable	(109)	(419)	931
Accrued and other liabilities	883	(221)	546
Net cash provided by operating activities	3,041	1,667	3,565
Cash flows from investing activities:
Purchases of property and equipment	(636)	(546)	(450)
Purchases of short-term investments	(1,493)	(3,722)	(2,667)
Proceeds from Maturities, Prepayments and Calls of Short-Term Investments	1,416	2,687	4,310
Proceeds from Sale of Short-Term Investments	616	300	0
Cash Acquired from Acquisition			2,366
Acquisitions, net of cash acquired, all others	(548)	(131)	(1,544)
Payments to Acquire Interest in Subsidiaries and Affiliates	(17)	0	0
Origination of Notes Receivable from Related Parties	(100)	0	0
Payments to Acquire Other Investments	(341)	(11)	(5)
Other	2	0	(11)
Net cash provided by (used in) investing activities	(1,101)	(1,423)	1,999
Cash flows from financing activities:
Proceeds from debt, net of issuance costs	0	0	991
Repayment of debt	(750)	0	(312)
Proceeds from sales of common stock through employee equity plans	279	268	167
Repurchases of common stock	(862)	(985)	(3,702)
Stock repurchases for tax withholding on employee equity plans	(728)	(427)	(406)
Other	(1)	(2)	(2)
Net cash used in financing activities	(2,062)	(1,146)	(3,264)
Net increase (decrease) in cash, cash equivalents and restricted cash	(122)	(902)	2,300
Cash, cash equivalents and restricted cash at beginning of year	3,933	4,835	2,535
Cash, cash equivalents and restricted cash at end of year	3,811	3,933	4,835
Cash paid during the year for:
Interest	72	84	85
Income taxes, net of refund	1,386	523	685
Non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	144	106	157
Stock Issued	0	0	48,514
Other Significant Noncash Transaction, Value of Consideration Given	0	0	275
Non-cash activities for leases:
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	102	273	115
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents	3,787	3,933	4,835
Restricted cash included in Prepaid expense and other current assets	24	0	0
Total cash, cash equivalents, and restricted cash	$ 3,811	$ 3,933	$ 4,835

The Company

The Company	12 Months Ended
	Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
The Company	The CompanyAdvanced Micro Devices, Inc. is a global semiconductor company. References herein to AMD or the Company mean Advanced Micro Devices, Inc. and its consolidated subsidiaries. AMD’s products include Artificial Intelligence (AI) Accelerators, x86 microprocessors (CPUs) and graphics processing units (GPUs), as standalone devices or as incorporated into accelerated processing units (APUs), chipsets, data center and professional GPUs, embedded processors, semi-custom System-on-Chip (SoC) products, microprocessor and SoC development services and technology, data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), System on Modules (SOMs), Smart Network Interface Cards (SmartNICs), and Adaptive SoC products. From time to time, the Company may also sell or license portions of its intellectual property (IP) portfolio.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 28, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Basis of Presentation and Significant Accounting Policies Fiscal Year . The Company uses a 52- or 53-week fiscal year ending on the last Saturday in December. Fiscal years 2024, 2023 and 2022 ended on December 28, 2024, December 30, 2023 and December 31, 2022, respectively. Fiscal years 2024 and 2023 each consisted of 52 weeks, while fiscal year 2022 consisted of 53 weeks. Principles of Consolidation. The Consolidated Financial Statements include the Company’s accounts and those of its wholly-owned subsidiaries. Upon consolidation, all inter-company accounts and transactions have been eliminated. Reclassification and Change in Presentation. Unbilled receivables of $1.1 billion as of December 30, 2023 were reclassified from within Accounts receivable, net to within Prepaid expenses and other current assets on the Company’s Consolidated Balance Sheets and in the Statements of Cash Flows to conform to current period presentation. Use of Estimates. The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results are likely to differ from those estimates, and such differences may be material to the financial statements. Areas where management uses subjective judgment include, but are not limited to, revenue allowances, inventory valuation, valuation of goodwill and long-lived and intangible assets, and income taxes. Revenue Recognition Revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. Sales, value-added, and other taxes collected concurrently with the provision of goods or services are excluded from revenue. Shipping and handling costs associated with product sales are included in cost of sales. Substantially all of the Company’s revenue is derived from product sales. Customers are generally required to pay for products and services within the Company’s standard contractual terms, which are typically net 30 to 60 days. The Company has determined that it does not have significant financing components in its contracts with customers. Non-custom products The Company transfers control and recognizes revenue when non-custom products are shipped to customers, which includes original equipment manufacturers (OEM) and distributors, in accordance with the shipping terms of the sale. Certain OEMs may be entitled to rights of return and rebates under OEM agreements. The Company also sells to distributors under terms allowing the majority of distributors certain rights of return and price protection on unsold merchandise held by them. The Company estimates the amount of variable consideration under OEM and distributor arrangements and, accordingly, records a provision for product returns, allowances for price protection and rebates based on actual historical experience and any known events. The Company offers incentive programs to certain customers, including cooperative advertising, marketing promotions, volume-based incentives and special pricing arrangements. Where funds provided for such programs can be estimated, the Company recognizes a reduction to revenue at the time the related revenue is recognized; otherwise, the Company recognizes such reduction to revenue at the later of when: i) the related revenue transaction occurs; or ii) the program is offered. For transactions where the Company reimburses a customer for a portion of the customer’s cost to perform specific product advertising or marketing and promotional activities, such amounts are recognized as a reduction to revenue unless they qualify for expense recognition. Constraints of variable consideration have not been material. Custom products Custom products, which are primarily associated with the Company’s Gaming segment, are sold under non-cancellable purchases orders, for which the Company has an enforceable right to payment, and which have no alternative use to the Company at contract inception, are recognized as revenue, over the time of production of the products by the Company. The Company utilizes a cost-based input method, calculated as cost incurred plus estimated margin, to determine the amount of revenue to recognize for in-process or completed customer orders at a reporting date. The Company believes that a cost-based input method is the most appropriate manner to measure how the Company satisfies its performance obligations to customers because the effort and costs incurred best depict the Company’s satisfaction of its performance obligation. Sales of custom products are not subject to a right of return and arrangements generally involve a single performance obligation. Generally, there are no variable consideration estimates associated with custom products. Development and intellectual property licensing agreements From time to time, the Company may enter into arrangements with customers that combine the provision of development services and a license to the right to use the Company’s IP. These arrangements are deemed to be single or multiple performance obligations based upon the nature of the arrangements. Revenue is recognized upon the transfer of control, over time or at a point in time, depending on the nature of the arrangements. The Company evaluates whether the licensing component is distinct. A licensing component is distinct if it is both (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license is not distinct, it is combined with the development services as a single performance obligation and recognized over time. If the license is distinct, revenue is recognized at a point in time when the customer has the ability to benefit from the license. From time to time, the Company may enter into arrangements with customers that solely involve the sale or licensing of its patents or IP. Generally, there are no performance obligations beyond transferring the designated license to the Company’s patents or IP. Accordingly, revenue is recognized at a point in time when the customer has the ability to benefit from the license. There are no variable consideration estimates associated with either combined development and IP arrangements or for standalone arrangements involving either the sale or licensing of IP. Inventories The Company values inventory at standard cost, adjusted to approximate the lower of actual cost or estimated net realizable value using assumptions about future demand and market conditions. In determining excess or obsolescence reserves for its products, the Company considers assumptions such as changes in business and economic conditions, other-than-temporary decreases in demand for its products, and changes in technology or customer requirements. In determining the lower of cost or net realizable value reserves, the Company considers assumptions such as recent historical sales activity and selling prices, as well as estimates of future selling prices. The Company fully reserves for inventories and non-cancellable purchase orders for inventory deemed obsolete. The Company performs periodic reviews of inventory items to identify excess inventories on hand by comparing on-hand balances and non-cancellable purchase orders to anticipated usage using recent historical activity as well as anticipated or forecasted demand. If estimates of customer demand diminish further or market conditions become less favorable than those projected by the Company, additional inventory carrying value adjustments may be required . Business Combinations The Company is required to use the acquisition method of accounting for business combinations. The acquisition method of accounting requires the Company to allocate the purchase consideration to the assets acquired and liabilities assumed from the acquiree based on their respective fair values as of the acquisition date. The excess of the fair value of purchase consideration over the fair value of these assets acquired and liabilities assumed is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Critical estimates in valuing intangible assets include, but are not limited to, expected future revenue growth rates and margins, future changes in technology, time to recreate customer relationships, useful lives, and discount rates. Fair value estimates are based on the assumptions that management believes a market participant would use in pricing the asset or liability. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. Goodwill The Company performs its goodwill impairment analysis as of the first day of the fourth quarter of each year and, if certain events or circumstances indicate that an impairment loss may have been incurred, on a more frequent basis. The analysis may include both qualitative and quantitative factors to assess the likelihood of an impairment. The Company has the option to first perform qualitative testing to determine if it is more likely than not that the fair value of a reporting unit exceeds its carrying amount. Qualitative factors include industry and market considerations, overall financial performance, share price trends and market capitalization and Company-specific events. If the Company concludes it is more likely than not that the fair value of a reporting unit exceeds its carrying amount, the Company does not proceed to perform a quantitative impairment test. If the Company concludes it is more likely than not that the fair value of a reporting unit is less than its carrying value or elects to bypass the qualitative test, a quantitative goodwill impairment test will be performed by comparing the fair value of each reporting unit to its carrying value. If a reporting unit’s fair value is determined to be less than its carrying value, a goodwill impairment charge is recognized for the amount by which the reporting unit’s fair value is less than its carrying value, not to exceed the total amount of goodwill allocated to that reporting unit. Long-Lived and Intangible Assets Long-lived and intangible assets to be held and used are reviewed for impairment if indicators of potential impairment exist and at least annually for indefinite-lived intangible assets. Impairment indicators are reviewed on a quarterly basis. Assets are grouped and evaluated for impairment at the lowest level of identifiable cash flows. When indicators of impairment exist and assets are held for use, the Company estimates future undiscounted cash flows attributable to the related asset groups. In the event such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the asset group or based on appraisals. Factors affecting impairment of assets held for use include the ability of the specific assets to generate separately identifiable positive cash flows. When assets are removed from operations and held for sale, the Company estimates impairment losses as the excess of the carrying value of the assets over their fair value. Market conditions are among the factors affecting impairment of assets held for sale. Changes in any of these factors could necessitate impairment recognition in future periods for assets held for use or assets held for sale. Cash Equivalents Cash equivalents consist of financial instruments that are readily convertible into cash and have original maturities of three months or less at the time of purchase. Accounts Receivable Accounts receivable are primarily comprised of trade receivables presented net of rebates, price protection and an allowance for credit loss. The Company manages its exposure to customer credit risk through credit limits, credit lines, ongoing monitoring procedures and credit approvals. While the Company maintains an allowance for customer credit losses, its accounts receivable write-offs have historically not been significant. Unbilled Receivables Unbilled receivables are recorded within Prepaid expenses and other current assets on the Company’s Consolidated Balance Sheets. Unbilled receivables primarily represent work completed on development services and on custom products under non-cancellable purchase orders that have no alternative use to the Company at contract inception, recognized as revenue but not yet invoiced to customers. Investments Available-for-Sale Debt Securities. Investments in marketable debt securities are available for use in current operations, including those with maturity dates beyond one year, and are classified within current assets on the Consolidated Balance Sheets. Available-for-sale debt securities are recorded at fair value, with the change in unrealized gains and losses, net of tax, reported as a separate component on the Consolidated Statements of Comprehensive Income until realized. Fair value is determined based on quoted market rates when observable or utilizing data points that are observable. Securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of the excess, if any, is caused by expected credit losses. Expected credit losses on securities are recognized in other income (expense) on the Consolidated Statements of Operations, and any remaining unrealized losses, net of tax, are included in Accumulated other comprehensive income (loss), in Consolidated Statements of Stockholders’ Equity. The Company uses the first-in, first-out method as basis of the cost of securities sold. Strategic Non-marketable Equity Securities. The Company’s investments in non-marketable securities of privately-held companies are held for long-term strategic purposes and are accounted for under the measurement alternative, defined as cost, less impairments, adjusted for subsequent observable price changes and are periodically assessed for impairment when events or circumstances indicate that a decline in value may have occurred. The Company's periodic assessment of impairment is made by considering available evidence, including the investee’s general market and industry conditions and product development status. The Company also assesses the investee’s ability to meet business milestones, its financial condition, and near-term prospects, including the rate at which the investee is using its cash, the investee’s need for possible additional funding at a lower valuation and any bona fide offer to purchase the investee. Fair Value Measurements The Company’s financial instruments are measured and recorded at fair value on a recurring basis, except for non-marketable equity investments in privately-held companies, which are generally accounted for under the measurement alternative. Fair Value Hierarchy The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. The guidance for fair value measurements requires that assets and liabilities carried at fair value be classified and disclosed in one of the following categories: Level 1 — Quoted (unadjusted) prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. Level 3 — Unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation. Property and Equipment Property and equipment are stated at cost. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives of two to 15 years for equipment, 34 to 44 years for buildings, and leasehold improvements are measured by the shorter of the remaining terms of the leases or the estimated useful economic lives of the improvements. Leases Operating and finance leases are recorded as right-of-use (ROU) assets and lease liabilities on the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating and finance lease ROU assets and liabilities are initially recognized based on the present value of lease payments over the lease term. In determining the present value of lease payments, the Company uses the implicit interest rate if readily determinable. When the implicit interest rate is not readily determinable, the Company uses its incremental borrowing rate, which is based on its collateralized borrowing capabilities over a similar term of the lease payments. When using the incremental borrowing rate, the Company utilizes the consolidated group incremental borrowing rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company has elected the accounting policy to not recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. Operating leases are included in operating lease ROU assets, other current liabilities, and long-term operating lease liabilities on the Company’s Consolidated Balance Sheets. The Company’s finance leases are immaterial. Foreign Currency Translation/Transactions The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. Assets and liabilities denominated in non-U.S. dollars have been remeasured into U.S. dollars at current exchange rates for monetary assets and liabilities and historical exchange rates for non-monetary assets and liabilities. Non-U.S. dollar denominated transactions have been remeasured at average exchange rates in effect during each period, except for those cost of sales and expense transactions related to non-monetary balance sheet amounts which have been remeasured at historical exchange rates. The gains or losses from foreign currency remeasurement are included in earnings. Marketing and Advertising Expenses Advertising costs are expensed as incurred. In addition, the Company’s marketing and advertising expenses include certain cooperative advertising funding obligations under customer incentive programs, which costs are recorded upon agreement with customers and vendor partners. Cooperative advertising expenses are recorded as marketing, general and administrative expense to the extent the cash paid does not exceed the estimated fair value of the advertising benefit received. Any excess of cash paid over the estimated fair value of the advertising benefit received is recorded as a reduction of revenue. Total marketing and advertising expenses for 2024, 2023 and 2022 were approximately $1.2 billion, $695 million and $683 million, respectively. Stock-Based Compensation The Company estimates stock-based compensation cost for stock options at the grant date based on the option’s fair value as calculated by the Black-Scholes model. For time-based restricted stock units (RSUs), fair value is based on the closing price of the Company’s common stock on the grant date. The Company estimates the grant-date fair value of RSUs that involve a market condition using the Monte Carlo simulation model. The Company estimates the grant-date fair value of stock to be issued under the Company’s Employee Stock Purchase plan (ESPP) using the Black-Scholes model. Compensation expense is recognized over the vesting period of the applicable award using the straight-line method, except for the compensation expense related to RSUs with performance or market conditions (PRSUs), which are recognized ratably for each vesting tranche from the service inception date to the end of the requisite service period. Forfeiture rates are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Contingencies From time to time the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. The Company is also subject to income tax, indirect tax or other tax claims by tax agencies in jurisdictions in which it conducts business. In addition, the Company is a party to environmental matters including local, regional, state and federal government clean-up activities at or near locations where the Company currently or has in the past conducted business. The Company is required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of reasonably possible losses. A determination of the amount of reserves required for these commitments and contingencies that would be charged to earnings, if any, includes assessing the probability of adverse outcomes and estimating the amount of potential losses. The required reserves, if any, may change due to new developments in each matter or changes in circumstances such as a change in settlement strategy. Income Taxes The Company computes the provision for income taxes using the liability method and recognizes deferred tax assets and liabilities for temporary differences between financial statement and income tax bases of assets and liabilities, as well as for operating loss and tax credit carryforwards. The Company measures deferred tax assets and liabilities using tax rates applicable to taxable income in effect for the years in which those tax assets are expected to be realized or settled and provides a valuation allowance against deferred tax assets when it cannot conclude that it is more likely than not that some or all deferred tax assets will be realized. The assessment requires significant judgment and is performed in each of the applicable taxing jurisdictions. In addition, the Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that they will be sustained, based on the technical merits of the positions, on examination by the jurisdictional tax authority. Interest and penalties related to income taxes are recorded within the Income tax provision (benefit) line in the Company’s Consolidated Statements of Operations. The Company is subject to the Global Intangible Low Taxed Income (GILTI) tax in the U.S. and recognizes deferred taxes for temporary basis differences that are expected to reverse as GILTI tax in future years. Recently Issued Accounting Standard Updates Adopted In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2023-07 Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures to enhance disclosures about significant segment expenses. This ASU is effective for the Company’s fiscal year 2024 and interim periods in fiscal year 2025. The Company adopted this standard in the fourth quarter of 2024. See Note 4 - Segment Reporting for further information. Recently Issued Accounting Standard Updates Not Yet Adopted In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures that requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for the Company’s fiscal year 2025. Early adoption is permitted. The Company is currently evaluating income tax disclosures related to its annual report for fiscal year 2025. In November 2024, the FASB issued ASU 2024-03 Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The new guidance is intended to provide investors enhanced disclosures and requires public companies to disaggregate key expense types. The update is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently evaluating the impact of this new standard on its Consolidated Financial Statements. Although there are several other new accounting pronouncements issued by the FASB, the Company does not believe any of these accounting pronouncements had or will have a material impact on its Consolidated Financial Statements.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	12 Months Ended
	Dec. 28, 2024
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Financial Statement Information Inventories December 28, December 30, (In millions) Raw materials $ 351 $ 279 Work in process 4,289 3,260 Finished goods 1,094 812 Total inventories $ 5,734 $ 4,351 Prepaid Expenses and Other Current Assets December 28, December 30, (In millions) Unbilled receivables $ 628 $ 1,053 Other 1,250 1,259 Total prepaid expenses and other current assets $ 1,878 $ 2,312 Property and Equipment, net December 28, December 30, (In millions) Land, building and leasehold improvements $ 853 $ 821 Equipment 2,798 2,346 Construction in progress 324 209 Property and equipment, gross 3,975 3,376 Accumulated depreciation (2,173) (1,787) Total property and equipment, net $ 1,802 $ 1,589 Depreciation expense for 2024, 2023 and 2022 was $454 million, $441 million and $439 million, respectively. Accrued Liabilities December 28, December 30, (In millions) Accrued marketing programs $ 1,063 $ 827 Accrued compensation and benefits 1,174 884 Customer-related liabilities 1,349 788 Other accrued and current liabilities 674 583 Total accrued liabilities $ 4,260 $ 3,082 Revenue Revenue allocated to remaining performance obligations that are unsatisfied (or partially unsatisfied) include amounts received from customers and amounts that will be invoiced and recognized as revenue in future periods for development services, IP licensing and product revenue. As of December 28, 2024, the aggregate transaction price allocated to remaining performance obligations under contracts with an original expected duration of more than one year was $85 million, of which $67 million is expected to be recognized in the next 12 months. The revenue allocated to remaining performance obligations does not include amounts which have an original expected duration of one year or less. Revenue recognized over time associated with custom products and development services accounted for approximately 8%, 25% and 24% of the Company’s revenue in 2024, 2023 and 2022, respectively.

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting Management, including the Chief Operating Decision Maker (CODM), who is the Company’s Chief Executive Officer, reviews and assesses operating performance using segment net revenue, consolidated cost of sales and operating expenses and operating income (loss). These performance measures include the allocation of expenses to the reportable segments based on management’s judgment. The CODM is regularly provided segment operating income to assess relative segment performance. The Company’s four reportable segments are: • the Data Center segment, which primarily includes Artificial Intelligence (AI) accelerators, server microprocessors (CPUs), graphics processing units (GPUs), accelerated processing units (APUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), Smart Network Interface Cards (SmartNICs) and Adaptive System-on-Chip (SoC) products for data centers; • the Client segment, which primarily includes CPUs, APUs, and chipsets for desktops and notebooks; • the Gaming segment, which primarily includes discrete GPUs, and semi-custom SoC products and development services; and • the Embedded segment, which primarily includes embedded CPUs, GPUs, APUs, FPGAs, System on Modules (SOMs), and Adaptive SoC products. From time to time, the Company may also sell or license portions of its IP portfolio. In addition to these reportable segments, the Company has an All Other category, which is not a reportable segment. This category primarily includes certain expenses and credits that are not allocated to any of the reportable segments because the CODM does not consider these expenses and credits in evaluating the performance of the reportable segments. This category primarily includes amortization of acquisition-related intangibles, employee stock-based compensation, acquisition-related and other costs, restructuring charges and licensing gain. Acquisition-related and other costs primarily include transaction costs, purchase price fair value adjustments for inventory, certain compensation charges, contract termination costs and workforce rebalancing charges. The following table provides a summary of net revenue and operating income (loss) by segment for 2024, 2023 and 2022. Year Ended December 28, December 30, December 31, (In millions) Net revenue: Data Center $ 12,579 $ 6,496 $ 6,043 Client 7,054 4,651 6,201 Gaming 2,595 6,212 6,805 Embedded 3,557 5,321 4,552 Total net revenue $ 25,785 $ 22,680 $ 23,601 Cost of sales and operating expenses: Data Center $ 9,097 $ 5,229 $ 4,195 Client 6,157 4,697 5,011 Gaming 2,305 5,241 5,852 Embedded 2,136 2,693 2,300 All Other 4,190 4,419 4,979 Total cost of sales and operating expenses $ 23,885 $ 22,279 $ 22,337 Operating income (loss): Data Center $ 3,482 $ 1,267 $ 1,848 Client 897 (46) 1,190 Gaming 290 971 953 Embedded 1,421 2,628 2,252 All Other (4,190) (4,419) (4,979) Total operating income $ 1,900 $ 401 $ 1,264 Segment cost of sales and operating expenses primarily include material, external manufacturing, labor and marketing and advertising costs, and exclude expenses and credits that are recorded within the All Other category. The following table provides items included in All Other category: Year Ended December 28, December 30, December 31, (In millions) Operating loss: Amortization of acquisition-related intangibles $ 2,394 $ 2,811 $ 3,548 Stock-based compensation expense 1,407 1,384 1,081 Acquisition-related and other costs 186 258 452 Restructuring charges 186 — — Inventory loss at contract manufacturer 65 — — Licensing gain (48) (34) (102) Total operating loss $ 4,190 $ 4,419 $ 4,979 The Company does not discretely allocate assets to its operating segments, nor does management evaluate operating segments using discrete asset information. The following table summarizes sales to external customers by geographic regions based on billing location of the customer: Year Ended December 28, December 30, December 31, (In millions) United States 8,693 7,837 8,049 China (including Hong Kong) 6,231 3,417 5,207 Singapore 3,614 2,231 1,380 Taiwan 3,301 1,841 2,369 Japan 1,767 4,629 4,177 Europe 1,625 2,030 1,773 Other regions 554 695 646 Total sales to external customers $ 25,785 $ 22,680 $ 23,601 The following table summarizes sales to a major customer that accounted for at least 10% of the Company’s consolidated net revenue for the respective years: Year Ended Segment December 28, December 30, December 31, Customer A Gaming * 18 % 16 % * Less than 10% The following table summarizes Property and equipment, net by geographic areas: December 28, December 30, (In millions) United States $ 1,312 $ 1,143 Singapore 140 144 Canada 104 84 India 100 86 Ireland 46 46 China (including Hong Kong) 38 42 Other countries 62 44 Total property and equipment, net $ 1,802 $ 1,589

Business Combinations and Asset

Business Combinations and Asset Acquisitions	12 Months Ended
	Dec. 28, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combination Disclosure	Business Combinations Fiscal Year 2024 Acquisitions Silo AI Acquisition On August 9, 2024, the Company completed the acquisition of Silo AI Oy (Silo AI), an AI lab based in Finland in an all-cash transaction of $665 million. Net of closing adjustments, transaction costs and deferred cash compensation, the purchase consideration of $553 million was allocated to $19 million of identifiable intangible assets, $43 million of net liabilities assumed, and $577 million to goodwill. Goodwill was attributed to Silo AI’s workforce who will help the Company accelerate the deployment and development of AI models and software solutions on AMD hardware. Silo AI financial results, which were not material, were included in the Company's Statement of Operations from the date of acquisition primarily within the Data Center segment. Pending Acquisition of ZT Systems On August 17, 2024, the Company entered into an agreement (the Agreement) to acquire ZT Group Int’l, Inc. (ZT Systems), a provider of AI and general purpose compute infrastructure for hyperscale computing companies, in a cash and stock transaction valued at approximately $4.9 billion (the Acquisition). The aggregate closing consideration payable by the Company consists of 8,335,852 shares of the Company’s common stock and $3.4 billion in cash. Contingent consideration of up to 740,964 shares of the Company’s common stock and up to $300 million of cash is payable by the Company to the extent certain conditions are met. The Agreement provides that if the Acquisition is not completed by August 17, 2025, subject to two automatic extensions until February 17, 2026, the Company will pay a termination fee of $300 million. The Acquisition is expected to close in the first half of 2025, subject to certain regulatory approvals and other customary closing conditions. The Company intends to seek a strategic partner to acquire ZT Systems' manufacturing business. Fiscal Year 2023 Acquisitions During the year ended December 30, 2023, the Company completed business acquisitions for a total consideration of $134 million that resulted in the recognition of $49 million of identifiable net assets and $85 million of goodwill. The financial results of these acquired businesses, which were not material, were included in the Company's Consolidated Statements of Operations from their respective dates of acquisition under the Data Center, Client and Embedded segments. Fiscal Year 2022 Acquisitions Pensando Acquisition On May 26, 2022, the Company completed the acquisition of all issued and outstanding shares of Pensando, a leader in next-generation distributed computing, for a transaction valued at approximately $1.9 billion. The recorded purchase consideration of $1.7 billion is net of deferred cash compensation requiring future services and other customary closing adjustments. The purchase consideration was allocated to $349 million of intangible assets, $208 million of identifiable net assets, and $1.1 billion of goodwill. From the acquisition date to December 30, 2022, the Consolidated Statements of Operations include immaterial revenue and operating results attributable to Pensando, which are reported under the Data Center segment. In 2023 and 2022, Pensando acquisition-related costs of $190 million and $102 million were recorded under Cost of sales, Research and development, and Marketing, general and administrative expenses on the Company’s Consolidated Statements of Operations. Pensando acquisition-related costs were immaterial in 2024. Acquisition-related costs are primarily comprised of direct transaction costs, fair value adjustments for acquired inventory and certain compensation charges. Xilinx Acquisition On February 14, 2022 (Xilinx Acquisition Date), the Company completed the acquisition of all issued and outstanding shares of Xilinx, a leading provider of adaptive computing solutions, for a total purchase consideration of $48.8 billion ($46.4 billion, net of cash acquired of $2.4 billion). The purchase consideration was allocated to $27.3 billion of intangible assets, $1.3 billion of identifiable net liabilities, and $22.8 billion of goodwill. The Consolidated Statements of Operations include the following revenue and operating income attributable to Xilinx in 2022: 2022 (In millions) Net revenue $ 4,612 Operating income $ 2,247 In 2022, operating income attributable to Xilinx recorded under the Embedded and Data Center segments does not include $4.2 billion of amortization of acquisition-related intangibles, employee stock-based compensation expense and acquisition-related costs, which are recorded under the “All Other” segment. In 2023 and 2022, Xilinx acquisition-related costs of $26 million and $350 million were recorded under Cost of sales, Research and development, and Marketing, general and administrative expenses on the Company’s Consolidated Statements of Operations. Xilinx acquisition-related costs in 2024 were immaterial. Acquisition-related costs are primarily comprised of direct transaction costs, fair value adjustments for acquired inventory and certain compensation charges. Supplemental Unaudited Pro Forma Information Following are the supplemental consolidated financial results of the Company, Xilinx and Pensando on an unaudited pro forma basis, as if the acquisitions had been consummated as of the beginning of the fiscal year 2022. December 31, (in millions) Net revenue $ 24,117 Net income $ 2,311
Goodwill	Acquisition-related Intangible Assets and Goodwill Acquisition-related Intangible Assets The following table summarizes Acquisition-related Intangible Assets: December 28, 2024 December 30, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (In millions) (In millions) Developed technology $ 13,408 $ (2,529) $ 10,879 $ 13,390 $ (1,583) $ 11,807 Customer relationships 12,324 (5,124) 7,200 12,324 (3,755) 8,569 Customer backlog 809 (809) — 809 (809) — Corporate trade name 65 (65) — 65 (65) — Product trademarks 914 (225) 689 914 (147) 767 Intangible assets subject to amortization 27,520 (8,752) 18,768 27,502 (6,359) 21,143 In-process Research and Development (IPR&D) not subject to amortization 162 — 162 220 — 220 Total acquisition-related intangible assets $ 27,682 $ (8,752) $ 18,930 $ 27,722 $ (6,359) $ 21,363 Acquisition-related intangible amortization expense was $2.4 billion and $2.8 billion in fiscal year 2024 and 2023, respectively. During the fourth quarter of fiscal year 2024, the Company determined that the fair value of certain IPR&D recorded within the Data Center segment was not recoverable resulting from actions related to the 2024 Restructuring Plan, and recorded an impairment charge of $58 million within Restructuring charges in the Company’s Consolidated Statement of Operations. Based on the carrying value of acquisition-related intangibles recorded as of December 28, 2024, and assuming no subsequent impairment of the underlying assets, the estimated annual amortization expense for acquisition-related intangibles is expected to be as follows: Fiscal Year (In millions) 2025 $ 2,225 2026 2,111 2027 1,993 2028 1,885 2029 1,659 2030 and thereafter 8,895 Total $ 18,768 Goodwill The following table summarizes changes in the carrying amount of Goodwill: December 31, 2022 Acquisitions December 30, 2023 Acquisitions December 28, (In millions) (In millions) Data Center $ 2,884 $ 58 $ 2,942 $ 461 $ 3,403 Client — 18 18 108 126 Gaming 238 — 238 — 238 Embedded 21,055 9 21,064 8 21,072 Total $ 24,177 $ 85 $ 24,262 $ 577 $ 24,839

Intangible Assets, Goodwill and

Intangible Assets, Goodwill and Other	12 Months Ended
	Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Acquisition-related Intangible Assets and Goodwill Acquisition-related Intangible Assets The following table summarizes Acquisition-related Intangible Assets: December 28, 2024 December 30, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (In millions) (In millions) Developed technology $ 13,408 $ (2,529) $ 10,879 $ 13,390 $ (1,583) $ 11,807 Customer relationships 12,324 (5,124) 7,200 12,324 (3,755) 8,569 Customer backlog 809 (809) — 809 (809) — Corporate trade name 65 (65) — 65 (65) — Product trademarks 914 (225) 689 914 (147) 767 Intangible assets subject to amortization 27,520 (8,752) 18,768 27,502 (6,359) 21,143 In-process Research and Development (IPR&D) not subject to amortization 162 — 162 220 — 220 Total acquisition-related intangible assets $ 27,682 $ (8,752) $ 18,930 $ 27,722 $ (6,359) $ 21,363 Acquisition-related intangible amortization expense was $2.4 billion and $2.8 billion in fiscal year 2024 and 2023, respectively. During the fourth quarter of fiscal year 2024, the Company determined that the fair value of certain IPR&D recorded within the Data Center segment was not recoverable resulting from actions related to the 2024 Restructuring Plan, and recorded an impairment charge of $58 million within Restructuring charges in the Company’s Consolidated Statement of Operations. Based on the carrying value of acquisition-related intangibles recorded as of December 28, 2024, and assuming no subsequent impairment of the underlying assets, the estimated annual amortization expense for acquisition-related intangibles is expected to be as follows: Fiscal Year (In millions) 2025 $ 2,225 2026 2,111 2027 1,993 2028 1,885 2029 1,659 2030 and thereafter 8,895 Total $ 18,768 Goodwill The following table summarizes changes in the carrying amount of Goodwill: December 31, 2022 Acquisitions December 30, 2023 Acquisitions December 28, (In millions) (In millions) Data Center $ 2,884 $ 58 $ 2,942 $ 461 $ 3,403 Client — 18 18 108 126 Gaming 238 — 238 — 238 Embedded 21,055 9 21,064 8 21,072 Total $ 24,177 $ 85 $ 24,262 $ 577 $ 24,839

Goodwill

Goodwill	12 Months Ended
	Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Acquisition-related Intangible Assets and Goodwill Acquisition-related Intangible Assets The following table summarizes Acquisition-related Intangible Assets: December 28, 2024 December 30, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (In millions) (In millions) Developed technology $ 13,408 $ (2,529) $ 10,879 $ 13,390 $ (1,583) $ 11,807 Customer relationships 12,324 (5,124) 7,200 12,324 (3,755) 8,569 Customer backlog 809 (809) — 809 (809) — Corporate trade name 65 (65) — 65 (65) — Product trademarks 914 (225) 689 914 (147) 767 Intangible assets subject to amortization 27,520 (8,752) 18,768 27,502 (6,359) 21,143 In-process Research and Development (IPR&D) not subject to amortization 162 — 162 220 — 220 Total acquisition-related intangible assets $ 27,682 $ (8,752) $ 18,930 $ 27,722 $ (6,359) $ 21,363 Acquisition-related intangible amortization expense was $2.4 billion and $2.8 billion in fiscal year 2024 and 2023, respectively. During the fourth quarter of fiscal year 2024, the Company determined that the fair value of certain IPR&D recorded within the Data Center segment was not recoverable resulting from actions related to the 2024 Restructuring Plan, and recorded an impairment charge of $58 million within Restructuring charges in the Company’s Consolidated Statement of Operations. Based on the carrying value of acquisition-related intangibles recorded as of December 28, 2024, and assuming no subsequent impairment of the underlying assets, the estimated annual amortization expense for acquisition-related intangibles is expected to be as follows: Fiscal Year (In millions) 2025 $ 2,225 2026 2,111 2027 1,993 2028 1,885 2029 1,659 2030 and thereafter 8,895 Total $ 18,768 Goodwill The following table summarizes changes in the carrying amount of Goodwill: December 31, 2022 Acquisitions December 30, 2023 Acquisitions December 28, (In millions) (In millions) Data Center $ 2,884 $ 58 $ 2,942 $ 461 $ 3,403 Client — 18 18 108 126 Gaming 238 — 238 — 238 Embedded 21,055 9 21,064 8 21,072 Total $ 24,177 $ 85 $ 24,262 $ 577 $ 24,839

Related Parties - Equity Joint

Related Parties - Equity Joint Ventures	12 Months Ended
	Dec. 28, 2024
Equity Method Investments and Joint Ventures [Abstract]
Related Parties - Equity Joint Ventures	Related Parties—Equity Joint Ventures ATMP Joint Venture s The Company holds a 15% equity interest in two joint ventures (collectively, the ATMP JV) with affiliates of Tongfu Microelectronics Co., Ltd, a Chinese joint stock company. The Company has no obligation to fund the ATMP JV. The Company accounts for its equity interests in the ATMP JV under the equity method of accounting due to its significant influence over the ATMP JV. The ATMP JV provides assembly, test, mark and packaging (ATMP) services to the Company. The Company assists the ATMP JV in its management of certain raw material inventory. The purchases from and resales to the ATMP JV of inventory under the Company’s inventory management program are reported within purchases and resales with the ATMP JV and do not impact the Company’s Consolidated Statement of Operations. The Company’s purchases from the ATMP JV during each of the years 2024 and 2023 amounted to $1.7 billion . As of December 28, 2024 and December 30, 2023, the amounts payable to the ATMP JV were $476 million and $363 million, respectively, and are included in Payables to related parties on the Company’s Consolidated Balance Sheets. The Company’s resales to the ATMP JV during 2024 and 2023 amounted to $121 million and $14 million, respectively . As of December 28, 2024 and December 30, 2023, the Company had receivables from ATMP JV of $12 million and $9 million, respectively , included in Receivables from related parties on the Company’s Consolidated Balance Sheets. On October 9, 2024, the Company entered into a one-year term loan agreement with one of the ATMP JVs for $100 million to provide funds for the ATMP JV’s general corporate purposes. The loan bears interest, payable quarterly, at the three months term Secured Overnight Financing Rate (SOFR) plus 50 basis points. The loan is secured by the ATMP JV’s receivable balance due from the Company. The loan may be extended for further terms of up to twelve months. The loan is recorded within Receivables from related parties on the Company’s Consolidated Balance Sheets. During 2024, 2023 and 2022, the Company recorded gains of $33 million, $16 million and $14 million in Equity income in investee on its Consolidated Statement of Operations, respectively. On August 8, 2024, the Company contributed $17 million to the ATMP JV, representing additional equity that is in proportion to the Company’s existing 15% equity interest. As of December 28, 2024 and December 30, 2023, the carrying value of the Company’s investment in the ATMP JV was approximately $149 million and $99 million, respectively, recorded as Investments: equity method on the Company’s Consolidated Balance Sheets. THATIC Joint Ventures The Company holds equity interests in two joint ventures (collectively, the THATIC JV) with Higon Information Technology Co., Ltd. (THATIC), a third-party Chinese entity. As of December 28, 2024 and December 30, 2023, the carrying value of the investment was zero. In February 2016, the Company licensed certain of its intellectual property (Licensed IP) to the THATIC JV, payable over several years upon achievement of certain milestones. The Company also receives a royalty based on the sales of the THATIC JV’s products developed on the basis of such Licensed IP. The Company classifies Licensed IP and royalty income associated with the February 2016 agreement as Licensing gain within operating income. During 2024 and 2023, the Company recognized $48 million and $34 million of licensing gain from royalty income under the agreement, respectively. As of December 28, 2024 and December 30, 2023, the Company had no receivables from the THATIC JV.

Debt and Revolving Credit Facil

Debt and Revolving Credit Facility	12 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
Debt Disclosure	Debt and Revolving Credit Facility Debt The Company’s total debt as of December 28, 2024 and December 30, 2023 consisted of: December 28, December 30, (In millions) 2.950% Senior Notes Due 2024 (2.950% Notes) $ — $ 750 2.375% Senior Notes Due 2030 (2.375% Notes) 750 750 3.924% Senior Notes Due 2032 (3.924% Notes) 500 500 4.393% Senior Notes Due 2052 (4.393% Notes) 500 500 Total debt (principal amount) 1,750 2,500 Unamortized debt discount and issuance costs (29) (32) Total debt (net) 1,721 2,468 Less: current portion of long-term debt and related unamortized debt premium and issuance costs — (751) Total long-term debt $ 1,721 $ 1,717 Assumed Xilinx Notes due 2024 and 2030 In connection with the acquisition of Xilinx, the Company assumed $1.5 billion in aggregate principal of Xilinx’s 2.950% Notes due 2024 and 2.375% Notes due 2030 (together, the Assumed Xilinx Notes ) which were recorded at fair value as of the Xilinx Acquisition Date. The Assumed Xilinx Notes are general unsecured senior obligations of the Company with semi-annual fixed interest payments due on June 1 and December 1. The 2.95% Notes with a principal amount of $750 million were repaid in June 2024. 3.924% Senior Notes Due 2032 and 4.393% Senior Notes Due 2052 On June 9, 2022, the Company issued $1.0 billion in aggregate principal amount of 3.924% Notes and 4.393% Notes. The 3.924% Notes and 4.393% Notes are general unsecured senior obligations of the Company. The interest is payable semi-annually on June 1 and December 1 of each year, commencing on December 1, 2022. The 3.924% and 4.393% Notes are governed by the terms of an indenture dated June 9, 2022 between the Company and US Bank Trust Company, National Association as trustee. The Company may redeem some or all of the 3.924% Notes and 4.393% Notes prior to March 1, 2032 and December 1, 2051, respectively, at a price equal to the greater of the present value of the principal amount and future interest through the maturity of the 3.924% Notes or 4.393% Notes or 100% of the principal amount plus accrued and unpaid interest. Holders have the right to require the Company to repurchase all or a portion of the 3.924% Notes or 4.393% Notes in the event that the Company undergoes a change of control as defined in the indenture, at a repurchase price of 101% of the principal amount plus accrued and unpaid interest. Additionally, an event of default may result in the acceleration of the maturity of the 3.924% Notes and 4.393% Notes. Future Payments on Total Debt As of December 28, 2024, the Company’s future debt payment obligations were as follows: Term Debt Year (In millions) 2025 - 2029 — 2030 and thereafter 1,750 Total $ 1,750 Revolving Credit Facility The Company has $3 billion available under a revolving credit agreement, as amended, that expires on April 29, 2027 (Revolving Credit Agreement). As of December 28, 2024 and December 30, 2023, the Company had no outstanding borrowings under the Revolving Credit Agreement. Revolving loans under the Revolving Credit Agreement can be either Secure Overnight Financing Rate (SOFR) Loans or Base Rate Loans (each as defined in the Revolving Credit Agreement) at the Company's option. Each SOFR Loan will bear interest at a rate per annum equal to the applicable SOFR plus a margin between 0.575% and 1.20%. Each Base Rate Loan will bear interest equal to the Base Rate plus a margin between 0.000% and 0.20%. The Revolving Credit Agreement also contains a sustainability-linked pricing component which provides for interest rate and facility fee reductions or increases based on the Company meeting or missing targets related to environmental sustainability, specifically greenhouse gas emissions. The Revolving Credit Agreement contains customary representations and warranties, affirmative and negative covenants, and events of default applicable to the Company and its subsidiaries. As of December 28, 2024, the Company was in compliance with these covenants. Commercial Paper

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 28, 2024
Investments, Debt and Equity Securities [Abstract]
Financial Instruments	Financial Instruments Financial Instruments Recorded at Fair Value on a Recurring Basis December 28, 2024 December 30, 2023 (In millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Total Cash equivalents Money market funds $ 1,496 $ — $ — $ 1,496 $ 969 $ — $ 969 Corporate debt securities — 806 — 806 — 753 753 U.S. government and agency securities 130 — — 130 1,252 — 1,252 Non-U.S. government and agency securities — 116 — 116 — 135 135 Time deposits and certificates of deposits — 107 — 107 — 205 205 Short-term investments Corporate debt securities — 814 — 814 — 506 506 Time deposits and certificates of deposits — 10 — 10 — 9 9 Asset-backed and mortgage-backed securities — 28 — 28 — 34 34 U.S. government and agency securities 332 82 — 414 1,209 28 1,237 Non-U.S. government and agency securities — 79 — 79 — 54 54 Other non-current assets Time deposits and certificates of deposits — 1 — 1 — 1 1 Deferred compensation plan and other investments 197 — 25 222 133 — 133 Total assets measured at fair value $ 2,155 $ 2,043 $ 25 $ 4,223 $ 3,563 $ 1,725 $ 5,288 Deferred compensation plan investments are primarily mutual fund investments held in a Rabbi trust established to maintain the Company’s executive deferred compensation plan. The following is a summary of cash equivalents and short-term investments: December 28, 2024 December 30, 2023 Cost/ Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cost/ Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value (in millions) (in millions) Asset-backed and mortgage-backed securities $ 30 $ — $ (2) $ 28 $ 35 $ — $ (2) $ 33 Corporate debt securities 1,621 — (1) 1,620 1,259 — — 1,259 Money market funds 1,496 — — 1,496 969 — — 969 Time deposits and certificates of deposits 117 — — 117 214 — — 214 U.S. government and agency securities 544 — — 544 2,487 3 — 2,490 Non-U.S. government and agency securities 195 — — 195 189 — — 189 $ 4,003 $ — $ (3) $ 4,000 $ 5,153 $ 3 $ (2) $ 5,154 As of December 28, 2024 and December 30, 2023, the Company did not have material available-for-sale debt securities which had been in a continuous unrealized loss position of more than twelve months. The contractual maturities of investments classified as available-for-sale are as follows: December 28, 2024 December 30, 2023 Amortized Cost Fair Value Amortized Cost Fair Value (In millions) (In millions) Due within 1 year $ 2,073 $ 2,073 $ 3,792 $ 3,792 Due in 1 year through 5 years 406 405 361 364 Due in 5 years and later 27 26 32 30 $ 2,506 $ 2,504 $ 4,185 $ 4,186 Financial Instruments Measured at Fair Value on a Non-Recurring Basis As of December 28, 2024 and December 30, 2023, the Company had non-marketable securities in privately-held companies of $468 million and $155 million, respectively, which are recorded at estimated fair value based on Level 3 inputs. Financial Instruments Not Recorded at Fair Value The carrying amounts and estimated fair values of the Company’s long-term debt are as follows: December 28, 2024 December 30, 2023 Carrying Estimated Carrying Estimated (In millions) (In millions) Current portion of long-term debt, net $ — $ — $ 751 $ 741 Long-term debt, net of current portion $ 1,721 $ 1,543 $ 1,717 $ 1,630 The estimated fair value of the Company’s long-term debt is based on Level 2 inputs of quoted prices for the Company’s debt and comparable instruments in inactive markets. The fair value of the Company’s accounts receivable, accounts payable and other short-term obligations approximate their carrying value based on existing terms. Hedging Transactions and Derivative Financial Instruments Foreign Currency Forward Contracts Designated as Accounting Hedges The Company enters into foreign currency forward contracts to hedge its exposure to foreign currency exchange rate risk related to future forecasted transactions denominated in currencies other than the U.S. Dollar. These contracts generally mature within 24 months and are designated as accounting hedges. As of December 28, 2024 and December 30, 2023, the notional value of the Company’s outstanding foreign currency forward contracts designated as cash flow hedges was $2.2 billion and $2.4 billion, respectively. The fair value of these contracts as of December 28, 2024 is recorded within Prepaid expenses and other current assets, Accrued liabilities and Other long-term liabilities of $6 million, $60 million and $11 million, respectively. As of December 30, 2023, the fair value of these contracts was recorded within Prepaid expenses and other current assets and Accrued liabilities of $24 million and $18 million, respectively. Foreign Currency Forward Contracts Not Designated as Accounting Hedges The Company also enters into foreign currency forward contracts to reduce the short-term effects of foreign currency fluctuations on certain receivables or payables denominated in currencies other than the U.S. Dollar. These forward contracts generally mature within 3 months and are not designated as accounting hedges. As of December 28, 2024 and December 30, 2023, the notional value of these outstanding contracts was $642 million and $568 million, respectively. The fair value of these contracts was not material as of December 28, 2024 and December 30, 2023. The cash flows associated with derivative instruments as cash flow hedging instruments are classified in the same category within the Consolidated Statement of Cash Flows as the cash flows of the related items.

Concentrations of Credit and Op

Concentrations of Credit and Operation Risk	12 Months Ended
	Dec. 28, 2024
Risks and Uncertainties [Abstract]
Concentrations of Credit and Operation Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of investments in time deposits, available-for-sale debt securities, equity investments and trade receivables. The Company places its investments with high credit quality financial institutions. At the time an investment is made, investments in commercial paper of industrial firms and financial institutions are rated A1, P1, F1 or better. The Company invests in bonds that are rated A, A2 or better and repurchase agreements, each of which have securities of the type and quality listed above as collateral. The Company believes that concentrations of credit risk with respect to trade receivables are limited because a large number of geographically diverse customers make up the Company’s customer base, thus diluting the trade credit risk. One customer accounted for approximately 24% and another customer accounted for 16% of the total consolidated accounts receivable balance as of December 28, 2024 and December 30, 2023, respectively. However, the Company does not believe the receivable balance from these customers represents a significant credit risk based on past collection experience and review of their current credit quality.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed based on the weighted-average number of shares outstanding. Diluted earnings per share is computed based on the weighted-average number of shares outstanding plus potentially dilutive shares outstanding during the period. Potentially dilutive shares are determined by applying the treasury stock method to the Company’s stock options, RSUs (including PRSUs), common stock to be issued under the ESPP and warrants. The following table sets forth the components of basic and diluted earnings per share: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions, except per share amounts) Numerator Net income for basic earnings per share $ 1,641 $ 854 $ 1,320 Denominator Basic weighted-average shares 1,620 1,614 1,561 Effect of potentially dilutive shares from employee equity plans 17 11 10 Diluted weighted-average shares 1,637 1,625 1,571 Earnings per share: Basic $ 1.01 $ 0.53 $ 0.85 Diluted $ 1.00 $ 0.53 $ 0.84 Potential shares from employee equity plans totaling 1 million, 6 million and 16 million weighted-average shares for 2024, 2023 and 2022, respectively, were not included in the earnings per share calculation because their inclusion would have been anti-dilutive.

Common Stock and Stock-Based In

Common Stock and Stock-Based Incentive Compensation Plans	12 Months Ended
	Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]
Common Stock and Stock-Based Incentive Compensation Plans	Common Stock and Stock-Based Compensation Common Stock Shares of common stock outstanding were as follows: Year Ended December 28, December 30, December 31, (In millions) Balance, beginning of period 1,616 1,612 1,207 Common stock issued in the acquisition of Xilinx — — 429 Common stock issued under employee equity plans 17 17 17 Repurchases of common stock (6) (10) (36) Common stock repurchases for tax withholding on equity awards (5) (4) (5) Issuance of common stock upon warrant exercise — 1 — Balance, end of period 1,622 1,616 1,612 Stock Repurchase Program The Company has an approved stock repurchase program authorizing repurchases of up to $12 billion of the Company’s common stock (Repurchase Program). During the year ended December 28, 2024, the Company repurchased 5.9 million shares of its common stock under the Repurchase Program for $862 million. As of December 28, 2024, $4.7 billion remained available for future stock repurchases under this program. This Repurchase Program does not obligate the Company to acquire any common stock, has no termination date and may be suspended or discontinued at any time. Stock-Based Compensation The Company’s employee equity programs are intended to attract, retain and motivate highly qualified employees. On May 18, 2023, the Company’s stockholders approved the AMD 2023 Equity Incentive Plan (the 2023 Plan), which supersedes the AMD 2004 Equity Incentive Plan and the Xilinx, Inc. 2007 Equity Incentive Plan (the Prior Plans). Outstanding awards granted under the Prior Plans will continue to be governed by the terms of the Prior Plans but no awards may be made under the Prior Plans on or after May 18, 2023. Under the 2023 Plan, 87,645,874 shares of the Company’s common stock are reserved and available for delivery pursuant to awards granted under the 2023 Plan. Generally, stock options granted under the 2023 Plan vest and become exercisable over a four-year period from the date of grant and expire within seven years after the grant date. Unvested shares from the 2023 Plan that are reacquired by the Company from forfeited outstanding equity awards become available for grant and may be reissued as new awards. Under the 2023 Plan, the Company can grant (i) stock options, and (ii) RSUs, including time-based RSUs and PRSUs. Stock Options. Under the 2023 Plan, nonstatutory and incentive stock options may be granted. The exercise price of the shares subject to each nonstatutory stock option and incentive stock option cannot be less than 100% of the fair market value of the Company’s common stock on the date of the grant. The exercise price of each option granted under the 2023 Plan must be paid in full at the time of the exercise. Time-based RSUs. Time-based RSUs are awards that can be granted to any employee, director or consultant and that obligate the Company to issue a specific number of shares of the Company’s common stock in the future if the vesting terms and conditions are satisfied. PRSUs. PRSUs can be granted to certain of the Company’s senior executives. The performance metrics can be financial performance, non-financial performance and/or market conditions. Each PRSU award reflects a target number of shares (Target Shares) that may be issued to an award recipient before adjusting based on the Company’s financial performance, non-financial performance and/or market conditions. The actual number of shares that a grant recipient receives at the end of the period may range from 0% to 250% of the Target Shares granted, depending upon the degree of achievement of the performance target designated by each individual award. ESPP. Under the 2017 Plan, eligible employees who participate in an offering period may have up to 15% of their eligible earnings withheld, up to certain limitations, to purchase shares of common stock at 85% of the lower of the fair market value on the first or the last business day of the six-month offering period. The offering periods commence in May and November each year. As of December 28, 2024, the Company had 60 million shares of common stock that were available for future grants and 34 million shares reserved for issuance upon the exercise of outstanding stock options or the vesting of unvested RSUs, including PRSUs, under the 2023 Plan and the Prior Plans. Valuation and Expense Stock-based compensation expense was allocated in the Company’s Consolidated Statements of Operations as follows: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Cost of sales $ 21 $ 30 $ 29 Research and development 1,079 1,002 697 Marketing, general, and administrative 307 352 355 Total stock-based compensation expense before income taxes 1,407 1,384 1,081 Income tax benefit (251) (249) (179) Total stock-based compensation expense, net of income taxes $ 1,156 $ 1,135 $ 902 Stock Options. The weighted-average estimated fair value of employee stock options granted during 2024, 2023 and 2022 was $68.38, $53.72 and $44.35 per share, respectively, using the following assumptions: December 28, 2024 December 30, 2023 December 31, 2022 Expected volatility 54.34 % 52.36% - 52.42% 51.28 % Risk-free interest rate 3.80 % 3.93% - 4.11% 3.00 % Expected dividends — % — % — % Expected life (in years) 4.98 4.96 - 5.04 4.75 The Company uses a combination of the historical volatility of its common stock and the implied volatility for publicly traded options on the Company’s common stock as the expected volatility assumption. The risk-free interest rate is based on the rate for a U.S. Treasury zero-coupon yield curve with a term that approximates the expected life of the option grant at the date closest to the option grant date. The expected dividend yield is zero as the Company does not expect to pay dividends in the near future. The expected term of employee stock options represents the weighted-average period the stock options are expected to remain outstanding. The following table summarizes stock option activity and related information: Outstanding Number Weighted- Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life (In millions, except share price) Balance as of December 30, 2023 3 $ 68.33 Granted — $ 134.27 Forfeited — $ 102.71 Exercised (1) $ 22.17 Balance as of December 28, 2024 2 $ 89.73 $ 81 3.92 Exercisable December 28, 2024 1 $ 74.61 $ 69 2.83 The total intrinsic value of stock options exercised for 2024, 2023 and 2022 was $86 million, $173 million and $139 million, respectively. As of December 28, 2024, the Company had $41 million of total unrecognized compensation expense related to stock options, which will be recognized over the weighted-average period of 2.71 years. Time-based RSUs. The weighted-average grant date fair values of time-based RSUs granted during 2024, 2023 and 2022 were $141.95, $106.28 and $92.92 per share, respectively. The following table summarizes time-based RSU activity and related information: Number Weighted- Average Grant Date Fair Value (In millions) Unvested shares as of December 30, 2023 32 $ 100.65 Granted 12 $ 141.95 Forfeited (1) $ 107.96 Vested (13) $ 101.35 Unvested shares as of December 28, 2024 30 $ 116.77 The total fair value of time-based RSUs vested during 2024, 2023 and 2022 was $2.0 billion, $1.1 billion and $889 million, respectively. As of December 28, 2024, the Company had $2.6 billion of total unrecognized compensation expense related to time-based RSUs, which will be recognized over the weighted-average period of 2.63 years. PRSUs. The weighted-average grant date fair values of PRSUs granted during 2024, 2023 and 2022 were $118.98, $134.87 and $121.12, respectively, using the following assumptions: December 28, 2024 December 30, 2023 December 31, 2022 Expected volatility 52.68% - 53.19% 51.12% - 56.22% 50.65% - 53.51% Risk-free interest rate 3.82% - 4.41% 4.30% - 4.36% 1.14%- 3.17% Expected dividends — % — % — % Expected term (in years) 2.48 - 3.00 2.17 - 3.00 2.07 - 3.07 The Company uses the historical volatility of its common stock and risk-free interest rate based on the rate for a U.S. Treasury zero-coupon yield curve with a term that approximates the expected life of the PRSUs grant at the date closest to the grant date. The expected dividend yield is zero as the Company does not expect to pay dividends in the near future. The expected term of PRSUs represents the requisite service periods of these PRSUs. The following table summarizes PRSU activity and related information: Number Weighted-Average (In millions) Unvested shares as of December 30, 2023 2 $ 117.65 Granted 1 $ 118.98 Forfeited — $ 132.80 Vested (1) $ 91.15 Unvested shares as of December 28, 2024 2 $ 139.31 The total fair value of PRSUs vested during 2024, 2023 and 2022 was $226 million, $100 million and $254 million, respectively. As of December 28, 2024, the Company had $154 million of total unrecognized compensation expense related to PRSUs, which will be recognized over the weighted-average period of 1.61 years. ESPP. The weighted-average grant date fair value for the ESPP during 2024, 2023 and 2022 was $43.80, $31.11 and $24.71 per share, respectively, using the following assumptions: December 28, 2024 December 30, 2023 December 31, 2022 Expected volatility 48.14% - 49.38% 45.74% - 49.40% 58.15% - 63.76% Risk-free interest rate 4.42% - 5.41% 5.13% - 5.46% 1.43% - 4.52% Expected dividends — % — % — % Expected term (in years) 0.50 0.50 0.50 The Company uses the historical volatility of its common stock and the risk-free interest rate based on the rate for a U.S. Treasury zero-coupon yield curve with a term that approximates the expected life of the ESPP grant at the date closest to the ESPP grant date. The expected dividend yield is zero as the Company does not expect to pay dividends in the near future. The expected term of the ESPP represents the six-month offering period. During 2024, 2 million shares of common stock were purchased under the ESPP at an average purchase price of $111 resulting in aggregate cash proceeds of $265 million. As of December 28, 2024, the Company had $43 million of total unrecognized compensation expense related to the ESPP, which will be recognized over the weighted-average period of 0.37 years.

Retirement Benefit Plans

Retirement Benefit Plans	12 Months Ended
	Dec. 28, 2024
Retirement Benefits [Abstract]
Retirement Benefit Plans	Retirement Benefit Plans The Company provides retirement benefit plans in the United States and certain foreign countries. The Company has a 401(k) retirement plan that allows participating employees in the United States to contribute as defined by the plan and subject to Internal Revenue Service limitations. The Company matches 75% of employees’ contributions up to 6% of their eligible compensation. The Company’s contributions to the 401(k) plan for 2024, 2023 and 2022 were approximately $78 million, $70 million and $47 million, respectively.

Restructuring and Related Activ

Restructuring and Related Activities	12 Months Ended
	Dec. 28, 2024
Restructuring and Related Activities [Abstract]
Restructuring, Impairment, and Other Activities Disclosure	Restructuring Charges In the fourth quarter of 2024, the Company implemented a restructuring plan (the 2024 Restructuring Plan) focused on driving efficiencies and aligning resources with the Company’s largest growth opportunities in the AI and enterprise markets. The 2024 Restructuring Plan will primarily reduce global workforce by approximately 4% of headcount. Restructuring charges are included within the All Other category presented in Note 4 – Segment Reporting. Significant asset impairment charges are discussed in Note 6 - Acquisition-related Intangible Assets and Goodwill. The Company expects actions associated with the 2024 Restructuring Plan to be substantially completed by the end of the first quarter of fiscal year 2025. As of December 28, 2024, $89 million of accrued restructuring charges are recorded within Accrued liabilities of the Company’s Consolidated Balance Sheets. The following table summarizes activities and components of liabilities related to the 2024 Restructuring Plan: Employee severance and benefits Asset impairment Total (in millions) Liability as of December 30, 2023 $ — $ — $ — Current period costs 113 73 186 Cash payments (24) — (24) Non-cash charges — (73) (73) Liability as of December 28, 2024 $ 89 $ — $ 89

Income Taxes

Income Taxes	12 Months Ended
	Dec. 28, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income before income taxes consists of the following: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) U.S. $ 2,369 $ 454 $ 2,093 Non-U.S. (347) 54 (895) Total pre-tax income including equity income in investee $ 2,022 $ 508 $ 1,198 The income tax provision (benefit) consists of: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Current: U.S. federal $ 1,338 $ 496 $ 1,191 U.S. state and local 64 27 31 Non-U.S. 142 150 161 Total 1,544 673 1,383 Deferred: U.S. federal (311) (860) (1,365) U.S. state and local 6 (29) (26) Non-U.S. (858) (130) (114) Total (1,163) (1,019) (1,505) Income tax provision (benefit) $ 381 $ (346) $ (122) The table below displays the reconciliation between statutory federal income taxes and the total income tax provision (benefit). Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Statutory federal income tax expense at 21% $ 425 $ 107 $ 252 Tax effect from intercompany integration transaction 373 — — Foreign rate detriment (benefit) 153 (11) 195 Interest and penalty 136 53 33 State income taxes, net of federal benefit 22 (2) (3) Foreign-Derived Intangible Income (FDII) deduction (275) (185) (261) Research credits (232) (169) (241) GILTI and other foreign inclusion (133) (138) (96) Stock-based and non-deductible compensation (101) (17) (6) Other 13 16 5 Income tax provision (benefit) $ 381 $ (346) $ (122) The Company recorded an income tax provision of $381 million and an income tax benefit of $346 million in 2024 and 2023, respectively, representing effective tax rates of 19% and (68)%, respectively. The increase in income tax provision in 2024 was primarily due to higher pre-tax income and a $373 million tax effect from an intercompany integration transaction. Beginning in 2022, provisions in the U.S. Tax Cuts and Jobs Act of 2017 require the Company to capitalize and amortize R&D expenditures rather than deducting the costs as incurred. The capitalization resulted in an increase in 2024 and 2023 taxable income which also increased the income eligible for the FDII tax benefit. As a part of the Xilinx acquisition and as a result of certain employment and operational commitments the Company has made in Singapore, the Company has been granted a Development and Expansion Incentive (DEI) that is effective through 2031. The DEI reduces the local tax on Singapore income from a statutory rate of 17% to 5% through 2031. Due to the current year pre-tax loss in Singapore, the Company did not receive any income tax or earnings per share benefit. Deferred income taxes reflect the net tax effects of tax carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the balances for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of December 28, 2024 and December 30, 2023 were as follows: December 28, December 30, (In millions) Deferred tax assets: Capitalized R&D $ 2,892 $ 1,753 Net operating loss carryovers 962 992 Accruals and reserves not currently deductible 829 574 Federal and state tax credit carryovers 679 660 Foreign R&D and investment tax credits 579 597 Employee benefits not currently deductible 334 302 Lease liability 182 181 Foreign tax credits 77 71 Other 111 96 Total deferred tax assets 6,645 5,226 Less: valuation allowance (2,136) (2,124) Total deferred tax assets, net of valuation allowance 4,509 3,102 Deferred tax liabilities: Acquired intangibles (3,614) (3,104) GILTI (222) (524) Right-of-use assets (182) (175) Other (152) (135) Total deferred tax liabilities (4,170) (3,938) Net deferred tax assets (liabilities) $ 339 $ (836) During 2024, the Company executed an intercompany integration transaction and remeasured associated deferred taxes, resulting in increases to the deferred tax liability for acquisition-related intangibles and the deferred tax asset for Capitalized R&D, partially offset by a decrease in the deferred tax liability for GILTI. The movement in the deferred tax valuation allowance was as follows: December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Balance at beginning of year $ 2,124 $ 2,078 $ 1,735 Charges to income tax expense and other accounts 9 41 112 Acquisition-related 3 5 231 Balance at end of year $ 2,136 $ 2,124 $ 2,078 Through the end of fiscal year 2024, the Company continued to maintain a valuation allowance of approximately $2.1 billion for certain federal, state, and foreign tax attributes. The federal valuation allowance maintained is due to limitations under Internal Revenue Code Section 382 or 383, separate return loss year rules, or dual consolidated loss rules. Certain state and foreign valuation allowance maintained is due to lack of sufficient sources of future taxable income. The Company’s U.S. federal and state net operating losses (NOLs) carryforwards as of December 28, 2024, were $134 million and $362 million, respectively. NOLs may be subject to limitations by the Internal Revenue Code and similar provisions. $27 million of U.S. federal NOLs will expire between 2025 and 2037, and $107 million of federal NOLs have no expiration date. State NOLs will expire at various dates through 2043. The difference between the amount of federal NOLs which are recorded on the Company’s Consolidated Balance Sheets as deferred tax assets and their related valuation allowance, and the amounts reported on the Company’s tax returns are the result of uncertain tax positions the Company has taken for which an income tax reserve has been recorded. The federal tax credits of $12 million will expire at various dates between 2037 and 2042. The state tax return credits of $804 million will expire at various dates between 2025 and 2039, except for the California R&D credit, which does not expire. The Company also has $620 million of credit carryforward in Canada that will expire between 2028 and 2044. A reconciliation of the Company's gross unrecognized tax benefits was as follows: December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Balance at beginning of year $ 1,463 $ 1,361 $ 275 Increases for tax positions taken in the current year 57 53 748 Increases for tax positions taken in prior years 24 57 104 Decreases for tax positions taken in prior years (18) (8) (12) Increases to tax positions taken in prior years through acquisitions — — 252 Decreases for settlements with taxing authorities and statute of limitation lapses (28) — (6) Balance at end of year $ 1,498 $ 1,463 $ 1,361 The amount of unrecognized tax benefits that would impact the effective tax rate if recognized was $1.3 billion, $1.3 billion and $1.2 billion as of December 28, 2024, December 30, 2023 and December 31, 2022, respectively. The Company had $298 million, $142 million and $81 million of accrued penalties and interest related to unrecognized tax benefits as of December 28, 2024, December 30, 2023 and December 31, 2022, respectively. As of December 28, 2024 and December 30, 2023, the Company had long-term income tax liabilities related to unrecognized tax benefits of $1.4 billion, recorded under Other long-term liabilities in the Company’s Consolidated Balance Sheets. The Company is subject to taxation in the U.S. and foreign jurisdictions. Earnings from non-U.S. activities are subject to local country income tax. The material jurisdiction in which the Company is subject to potential examination by the taxing authority is the United States, where tax years from 2008 are open for audit. Pre-acquisition Xilinx U.S. tax returns for fiscal years 2018 and 2019 are currently under audit by the IRS. It is possible the Company may have tax audits close in the next 12 months that could materially change the balance of the uncertain tax benefits; however, the timing of tax audit closures and settlements are highly uncertain. Under current U.S. tax law, the impact of future distributions of undistributed earnings that are indefinitely reinvested are anticipated to be subject to withholding taxes from local jurisdictions and non-conforming U.S. state jurisdictions. There were no cumulative undistributed earnings that are indefinitely reinvested that could be subject to withholding taxes as of December 28, 2024.

Other Expense, Net

Other Expense, Net	12 Months Ended
	Dec. 28, 2024
Income Statement Related Disclosures [Abstract]
Other Expense, Net	Other Income (Expense), Net The following table summarizes the components of Other income (expense), net: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Interest income $ 182 $ 206 $ 65 Gains (losses) on equity investments, net 2 (1) (62) Other income (expense) (3) (8) 5 Other income (expense), net $ 181 $ 197 $ 8

Commitments and Guarantees

Commitments and Guarantees	12 Months Ended
	Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Guarantees	Commitments and Guarantees Operating Leases The Company has entered into operating and finance leases for its corporate offices, data centers, research and development facilities and certain equipment. The leases expire at various dates through 2038, some of which include options to extend the lease for up to ten years. For 2024, 2023 and 2022, the Company recorded $147 million, $127 million and $118 million, respectively, of operating lease expense, including short-term lease expense. For 2024, 2023, and 2022, the Company recorded $83 million, $46 million, and $40 million respectively, of variable lease expense, which primarily included operating expenses and property taxes associated with the usage of facilities under the operating leases. For 2024, 2023, and 2022 cash paid for operating leases included in operating cash flows was $155 million $147 million and $108 million, respectively. The Company’s finance and short-term leases are immaterial to the Company’s consolidated financial statements. Supplemental information related to leases is as follows: December 28, 2024 Weighted-average remaining lease term in years – operating leases 7.28 Weighted-average discount rate – operating leases 4.63 % Future minimum lease payments under non-cancellable operating lease liabilities as of December 28, 2024 are as follows: Year (In millions) 2025 $ 134 2026 135 2027 94 2028 66 2029 60 2030 and thereafter 235 Total minimum lease payments 724 Less: interest (124) Present value of net minimum lease payments 600 Less: current portion (109) Total long-term operating lease liabilities $ 491 Certain other operating leases contain provisions for escalating lease payments subject to changes in the consumer price index. Commitments The Company’s purchase commitments primarily include the Company’s obligations to purchase wafers and substrates from third parties and future payments related to certain software and technology licenses and IP licenses. Purchase commitments include obligations made under noncancellable purchase orders and contractual obligations requiring minimum purchases or for which cancellation would lead to significant penalties. Total future unconditional purchase commitments as of December 28, 2024 were as follows: Year (In millions) 2025 $ 4,501 2026 274 2027 46 2028 46 2029 45 2030 and thereafter 56 Total unconditional purchase commitments $ 4,968 On an ongoing basis, the Company works with suppliers on the timing of payments and deliveries of purchase commitments, taking into account business conditions. Warranties and Indemnities The Company generally warrants that its products sold to its customers will conform to its approved specifications and be free from defects in material and workmanship under normal use and conditions for one year. The Company may also offer, in general, one to three-year limited warranties based on product type and negotiated warranty terms with certain customers. The Company accrues warranty costs to Cost of sales at the time of sale of warranted products. Changes in the Company’s estimated liability for product warranty during 2024 and 2023 are as follows: December 28, December 30, (In millions) Beginning balance $ 85 $ 65 Provisions during the period 213 126 Settlements during the period (110) (106) Ending balance $ 188 $ 85 In addition to product warranties, the Company from time to time in its normal course of business indemnifies other parties with whom it enters into contractual relationships, including customers, lessors and parties to other transactions with the Company, with respect to certain matters. In these limited matters, the Company has agreed to hold certain third parties harmless against specific types of claims or losses such as those arising from a breach of representations or covenants, third-party claims that the Company’s products when used for their intended purpose(s) and under specific conditions infringe the intellectual property rights of a third party, or other specified claims made against the indemnified party. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, payments made by the Company under these obligations have not been material. In addition, the impact from changes in estimates for pre-existing warranties has been immaterial.

Contingencies

Contingencies	12 Months Ended
	Dec. 28, 2024
Loss Contingency [Abstract]
Contingencies	Contingencies Litigation and Other Legal Matters As of December 28, 2024, there were no material legal proceedings. The Company is a defendant or plaintiff in various actions that arose in the normal course of business. With respect to these matters, based on management’s current knowledge, the Company believes that the amount or range of reasonably possible loss, if any, will not, either individually or in the aggregate, have a material adverse effect on the Company’s financial condition, results of operations, or cash flows.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income	$ 1,641	$ 854	$ 1,320

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Dec. 28, 2024 shares	Dec. 28, 2024 shares
Individual Counterparty [Member]
Trading Arrangements, by Individual
Name	Lisa Su
Lisa Su [Member]
Trading Arrangements, by Individual
Title		Chair, President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 2, 2024
Expiration Date	December 10, 2025
Aggregate Available	750,000	750,000
Mark Papermaster [Member]
Trading Arrangements, by Individual
Name	Mark Papermaster
Title		Executive Vice President, Chief Technology Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 5, 2024
Expiration Date	December 31, 2025
Aggregate Available	173,006	173,006

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 28, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Accounting Policies [Abstract]
Fiscal Year	Fiscal Year . The Company uses a 52- or 53-week fiscal year ending on the last Saturday in December. Fiscal years 2024, 2023 and 2022 ended on December 28, 2024, December 30, 2023 and December 31, 2022, respectively. Fiscal years 2024 and 2023 each consisted of 52 weeks, while fiscal year 2022 consisted of 53 weeks.
Principles of Consolidation	Principles of Consolidation. The Consolidated Financial Statements include the Company’s accounts and those of its wholly-owned subsidiaries. Upon consolidation, all inter-company accounts and transactions have been eliminated.
Reclassification		Reclassification and Change in Presentation.
Use of Estimates	Use of Estimates. The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results are likely to differ from those estimates, and such differences may be material to the financial statements. Areas where management uses subjective judgment include, but are not limited to, revenue allowances, inventory valuation, valuation of goodwill and long-lived and intangible assets, and income taxes.
Revenue Recognition	Revenue Recognition Revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. Sales, value-added, and other taxes collected concurrently with the provision of goods or services are excluded from revenue. Shipping and handling costs associated with product sales are included in cost of sales. Substantially all of the Company’s revenue is derived from product sales. Customers are generally required to pay for products and services within the Company’s standard contractual terms, which are typically net 30 to 60 days. The Company has determined that it does not have significant financing components in its contracts with customers. Non-custom products The Company transfers control and recognizes revenue when non-custom products are shipped to customers, which includes original equipment manufacturers (OEM) and distributors, in accordance with the shipping terms of the sale. Certain OEMs may be entitled to rights of return and rebates under OEM agreements. The Company also sells to distributors under terms allowing the majority of distributors certain rights of return and price protection on unsold merchandise held by them. The Company estimates the amount of variable consideration under OEM and distributor arrangements and, accordingly, records a provision for product returns, allowances for price protection and rebates based on actual historical experience and any known events. The Company offers incentive programs to certain customers, including cooperative advertising, marketing promotions, volume-based incentives and special pricing arrangements. Where funds provided for such programs can be estimated, the Company recognizes a reduction to revenue at the time the related revenue is recognized; otherwise, the Company recognizes such reduction to revenue at the later of when: i) the related revenue transaction occurs; or ii) the program is offered. For transactions where the Company reimburses a customer for a portion of the customer’s cost to perform specific product advertising or marketing and promotional activities, such amounts are recognized as a reduction to revenue unless they qualify for expense recognition. Constraints of variable consideration have not been material. Custom products Custom products, which are primarily associated with the Company’s Gaming segment, are sold under non-cancellable purchases orders, for which the Company has an enforceable right to payment, and which have no alternative use to the Company at contract inception, are recognized as revenue, over the time of production of the products by the Company. The Company utilizes a cost-based input method, calculated as cost incurred plus estimated margin, to determine the amount of revenue to recognize for in-process or completed customer orders at a reporting date. The Company believes that a cost-based input method is the most appropriate manner to measure how the Company satisfies its performance obligations to customers because the effort and costs incurred best depict the Company’s satisfaction of its performance obligation. Sales of custom products are not subject to a right of return and arrangements generally involve a single performance obligation. Generally, there are no variable consideration estimates associated with custom products. Development and intellectual property licensing agreements From time to time, the Company may enter into arrangements with customers that combine the provision of development services and a license to the right to use the Company’s IP. These arrangements are deemed to be single or multiple performance obligations based upon the nature of the arrangements. Revenue is recognized upon the transfer of control, over time or at a point in time, depending on the nature of the arrangements. The Company evaluates whether the licensing component is distinct. A licensing component is distinct if it is both (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license is not distinct, it is combined with the development services as a single performance obligation and recognized over time. If the license is distinct, revenue is recognized at a point in time when the customer has the ability to benefit from the license. From time to time, the Company may enter into arrangements with customers that solely involve the sale or licensing of its patents or IP. Generally, there are no performance obligations beyond transferring the designated license to the Company’s patents or IP. Accordingly, revenue is recognized at a point in time when the customer has the ability to benefit from the license. There are no variable consideration estimates associated with either combined development and IP arrangements or for standalone arrangements involving either the sale or licensing of IP.
Inventories	Inventories The Company values inventory at standard cost, adjusted to approximate the lower of actual cost or estimated net realizable value using assumptions about future demand and market conditions. In determining excess or obsolescence reserves for its products, the Company considers assumptions such as changes in business and economic conditions, other-than-temporary decreases in demand for its products, and changes in technology or customer requirements. In determining the lower of cost or net realizable value reserves, the Company considers assumptions such as recent historical sales activity and selling prices, as well as estimates of future selling prices. The Company fully reserves for inventories and non-cancellable purchase orders for inventory deemed obsolete. The Company performs periodic reviews of inventory items to identify excess inventories on hand by comparing on-hand balances and non-cancellable purchase orders to anticipated usage using recent historical activity as well as anticipated or forecasted demand. If estimates of customer demand diminish further or market conditions become less favorable than those projected by the Company, additional inventory carrying value adjustments may be required .
Goodwill	Goodwill The Company performs its goodwill impairment analysis as of the first day of the fourth quarter of each year and, if certain events or circumstances indicate that an impairment loss may have been incurred, on a more frequent basis. The analysis may include both qualitative and quantitative factors to assess the likelihood of an impairment. The Company has the option to first perform qualitative testing to determine if it is more likely than not that the fair value of a reporting unit exceeds its carrying amount. Qualitative factors include industry and market considerations, overall financial performance, share price trends and market capitalization and Company-specific events. If the Company concludes it is more likely than not that the fair value of a reporting unit exceeds its carrying amount, the Company does not proceed to perform a quantitative impairment test. If the Company concludes it is more likely than not that the fair value of a reporting unit is less than its carrying value or elects to bypass the qualitative test, a quantitative goodwill impairment test will be performed by comparing the fair value of each reporting unit to its carrying value. If a reporting unit’s fair value is determined to be less than its carrying value, a goodwill impairment charge is recognized for the amount by which the reporting unit’s fair value is less than its carrying value, not to exceed the total amount of goodwill allocated to that reporting unit.
Contingencies	Contingencies From time to time the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. The Company is also subject to income tax, indirect tax or other tax claims by tax agencies in jurisdictions in which it conducts business. In addition, the Company is a party to environmental matters including local, regional, state and federal government clean-up activities at or near locations where the Company currently or has in the past conducted business. The Company is required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of reasonably possible losses. A determination of the amount of reserves required for these commitments and contingencies that would be charged to earnings, if any, includes assessing the probability of adverse outcomes and estimating the amount of potential losses. The required reserves, if any, may change due to new developments in each matter or changes in circumstances such as a change in settlement strategy.
Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy	Cash Equivalents
Investments in Available-for-sale Debt Securities	Investments Available-for-Sale Debt Securities. Investments in marketable debt securities are available for use in current operations, including those with maturity dates beyond one year, and are classified within current assets on the Consolidated Balance Sheets. Available-for-sale debt securities are recorded at fair value, with the change in unrealized gains and losses, net of tax, reported as a separate component on the Consolidated Statements of Comprehensive Income until realized. Fair value is determined based on quoted market rates when observable or utilizing data points that are observable. Securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of the excess, if any, is caused by expected credit losses. Expected credit losses on securities are recognized in other income (expense) on the Consolidated Statements of Operations, and any remaining unrealized losses, net of tax, are included in Accumulated other comprehensive income (loss), in Consolidated Statements of Stockholders’ Equity. The Company uses the first-in, first-out method as basis of the cost of securities sold. Strategic Non-marketable Equity Securities. The Company’s investments in non-marketable securities of privately-held companies are held for long-term strategic purposes and are accounted for under the measurement alternative, defined as cost, less impairments, adjusted for subsequent observable price changes and are periodically assessed for impairment when events or circumstances indicate that a decline in value may have occurred. The Company's periodic assessment of impairment is made by considering available evidence, including the investee’s general market and industry conditions and product development status. The Company also assesses the investee’s ability to meet business milestones, its financial condition, and near-term prospects, including the rate at which the investee is using its cash, the investee’s need for possible additional funding at a lower valuation and any bona fide offer to purchase the investee.
Accounts Receivables	Accounts Receivable Accounts receivable are primarily comprised of trade receivables presented net of rebates, price protection and an allowance for credit loss. The Company manages its exposure to customer credit risk through credit limits, credit lines, ongoing monitoring procedures and credit approvals. While the Company maintains an allowance for customer credit losses, its accounts receivable write-offs have historically not been significant. Unbilled Receivables Unbilled receivables are recorded within Prepaid expenses and other current assets on the Company’s Consolidated Balance Sheets. Unbilled receivables primarily represent work completed on development services and on custom products under non-cancellable purchase orders that have no alternative use to the Company at contract inception, recognized as revenue but not yet invoiced to customers.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives of two to 15 years for equipment, 34 to 44 years for buildings, and leasehold improvements are measured by the shorter of the remaining terms of the leases or the estimated useful economic lives of the improvements.
Leases	Leases Operating and finance leases are recorded as right-of-use (ROU) assets and lease liabilities on the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating and finance lease ROU assets and liabilities are initially recognized based on the present value of lease payments over the lease term. In determining the present value of lease payments, the Company uses the implicit interest rate if readily determinable. When the implicit interest rate is not readily determinable, the Company uses its incremental borrowing rate, which is based on its collateralized borrowing capabilities over a similar term of the lease payments. When using the incremental borrowing rate, the Company utilizes the consolidated group incremental borrowing rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company has elected the accounting policy to not recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. Operating leases are included in operating lease ROU assets, other current liabilities, and long-term operating lease liabilities on the Company’s Consolidated Balance Sheets. The Company’s finance leases are immaterial.
Foreign Currency Translation/Transactions	Foreign Currency Translation/Transactions
Marketing and Advertising Expenses	Marketing and Advertising Expenses
Stock-Based Compensation	Stock-Based Compensation The Company estimates stock-based compensation cost for stock options at the grant date based on the option’s fair value as calculated by the Black-Scholes model. For time-based restricted stock units (RSUs), fair value is based on the closing price of the Company’s common stock on the grant date. The Company estimates the grant-date fair value of RSUs that involve a market condition using the Monte Carlo simulation model. The Company estimates the grant-date fair value of stock to be issued under the Company’s Employee Stock Purchase plan (ESPP) using the Black-Scholes model. Compensation expense is recognized over the vesting period of the applicable award using the straight-line method, except for the compensation expense related to RSUs with performance or market conditions (PRSUs), which are recognized ratably for each vesting tranche from the service inception date to the end of the requisite service period. Forfeiture rates are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Income Taxes	Income Taxes
Recently Adopted and Issued Accounting Standards	Recently Issued Accounting Standard Updates Adopted In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2023-07 Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures to enhance disclosures about significant segment expenses. This ASU is effective for the Company’s fiscal year 2024 and interim periods in fiscal year 2025. The Company adopted this standard in the fourth quarter of 2024. See Note 4 - Segment Reporting for further information. Recently Issued Accounting Standard Updates Not Yet Adopted In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures that requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for the Company’s fiscal year 2025. Early adoption is permitted. The Company is currently evaluating income tax disclosures related to its annual report for fiscal year 2025. In November 2024, the FASB issued ASU 2024-03 Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The new guidance is intended to provide investors enhanced disclosures and requires public companies to disaggregate key expense types. The update is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently evaluating the impact of this new standard on its Consolidated Financial Statements.
Fair Value Measurement, Policy	Fair Value Measurements The Company’s financial instruments are measured and recorded at fair value on a recurring basis, except for non-marketable equity investments in privately-held companies, which are generally accounted for under the measurement alternative. Fair Value Hierarchy The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. The guidance for fair value measurements requires that assets and liabilities carried at fair value be classified and disclosed in one of the following categories: Level 1 — Quoted (unadjusted) prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Business Combinations Policy	Business Combinations The Company is required to use the acquisition method of accounting for business combinations. The acquisition method of accounting requires the Company to allocate the purchase consideration to the assets acquired and liabilities assumed from the acquiree based on their respective fair values as of the acquisition date. The excess of the fair value of purchase consideration over the fair value of these assets acquired and liabilities assumed is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Critical estimates in valuing intangible assets include, but are not limited to, expected future revenue growth rates and margins, future changes in technology, time to recreate customer relationships, useful lives, and discount rates. Fair value estimates are based on the assumptions that management believes a market participant would use in pricing the asset or liability. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy	Long-Lived and Intangible Assets Long-lived and intangible assets to be held and used are reviewed for impairment if indicators of potential impairment exist and at least annually for indefinite-lived intangible assets. Impairment indicators are reviewed on a quarterly basis. Assets are grouped and evaluated for impairment at the lowest level of identifiable cash flows. When indicators of impairment exist and assets are held for use, the Company estimates future undiscounted cash flows attributable to the related asset groups. In the event such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the asset group or based on appraisals. Factors affecting impairment of assets held for use include the ability of the specific assets to generate separately identifiable positive cash flows. When assets are removed from operations and held for sale, the Company estimates impairment losses as the excess of the carrying value of the assets over their fair value. Market conditions are among the factors affecting impairment of assets held for sale. Changes in any of these factors could necessitate impairment recognition in future periods for assets held for use or assets held for sale.

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	12 Months Ended
	Dec. 28, 2024
Balance Sheet Related Disclosures [Abstract]
Inventories, net	Inventories December 28, December 30, (In millions) Raw materials $ 351 $ 279 Work in process 4,289 3,260 Finished goods 1,094 812 Total inventories $ 5,734 $ 4,351
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure	Prepaid Expenses and Other Current Assets December 28, December 30, (In millions) Unbilled receivables $ 628 $ 1,053 Other 1,250 1,259 Total prepaid expenses and other current assets $ 1,878 $ 2,312
Property and Equipment, net	Property and Equipment, net December 28, December 30, (In millions) Land, building and leasehold improvements $ 853 $ 821 Equipment 2,798 2,346 Construction in progress 324 209 Property and equipment, gross 3,975 3,376 Accumulated depreciation (2,173) (1,787) Total property and equipment, net $ 1,802 $ 1,589
Accrued Liabilities	Accrued Liabilities December 28, December 30, (In millions) Accrued marketing programs $ 1,063 $ 827 Accrued compensation and benefits 1,174 884 Customer-related liabilities 1,349 788 Other accrued and current liabilities 674 583 Total accrued liabilities $ 4,260 $ 3,082

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The following table provides a summary of net revenue and operating income (loss) by segment for 2024, 2023 and 2022. Year Ended December 28, December 30, December 31, (In millions) Net revenue: Data Center $ 12,579 $ 6,496 $ 6,043 Client 7,054 4,651 6,201 Gaming 2,595 6,212 6,805 Embedded 3,557 5,321 4,552 Total net revenue $ 25,785 $ 22,680 $ 23,601 Cost of sales and operating expenses: Data Center $ 9,097 $ 5,229 $ 4,195 Client 6,157 4,697 5,011 Gaming 2,305 5,241 5,852 Embedded 2,136 2,693 2,300 All Other 4,190 4,419 4,979 Total cost of sales and operating expenses $ 23,885 $ 22,279 $ 22,337 Operating income (loss): Data Center $ 3,482 $ 1,267 $ 1,848 Client 897 (46) 1,190 Gaming 290 971 953 Embedded 1,421 2,628 2,252 All Other (4,190) (4,419) (4,979) Total operating income $ 1,900 $ 401 $ 1,264 Segment cost of sales and operating expenses primarily include material, external manufacturing, labor and marketing and advertising costs, and exclude expenses and credits that are recorded within the All Other category. The following table provides items included in All Other category: Year Ended December 28, December 30, December 31, (In millions) Operating loss: Amortization of acquisition-related intangibles $ 2,394 $ 2,811 $ 3,548 Stock-based compensation expense 1,407 1,384 1,081 Acquisition-related and other costs 186 258 452 Restructuring charges 186 — — Inventory loss at contract manufacturer 65 — — Licensing gain (48) (34) (102) Total operating loss $ 4,190 $ 4,419 $ 4,979
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area	The following table summarizes sales to external customers by geographic regions based on billing location of the customer: Year Ended December 28, December 30, December 31, (In millions) United States 8,693 7,837 8,049 China (including Hong Kong) 6,231 3,417 5,207 Singapore 3,614 2,231 1,380 Taiwan 3,301 1,841 2,369 Japan 1,767 4,629 4,177 Europe 1,625 2,030 1,773 Other regions 554 695 646 Total sales to external customers $ 25,785 $ 22,680 $ 23,601
Schedule of Revenue by Major Customers by Reporting Segments	The following table summarizes sales to a major customer that accounted for at least 10% of the Company’s consolidated net revenue for the respective years: Year Ended Segment December 28, December 30, December 31, Customer A Gaming * 18 % 16 % * Less than 10%
Summary of Property and Equipment by Geographic region	The following table summarizes Property and equipment, net by geographic areas: December 28, December 30, (In millions) United States $ 1,312 $ 1,143 Singapore 140 144 Canada 104 84 India 100 86 Ireland 46 46 China (including Hong Kong) 38 42 Other countries 62 44 Total property and equipment, net $ 1,802 $ 1,589

Business Combinations and Ass_2

Business Combinations and Asset Acquisitions (Tables)	12 Months Ended
	Dec. 28, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Based on the carrying value of acquisition-related intangibles recorded as of December 28, 2024, and assuming no subsequent impairment of the underlying assets, the estimated annual amortization expense for acquisition-related intangibles is expected to be as follows: Fiscal Year (In millions) 2025 $ 2,225 2026 2,111 2027 1,993 2028 1,885 2029 1,659 2030 and thereafter 8,895 Total $ 18,768
Schedule of Goodwill	December 31, 2022 Acquisitions December 30, 2023 Acquisitions December 28, (In millions) (In millions) Data Center $ 2,884 $ 58 $ 2,942 $ 461 $ 3,403 Client — 18 18 108 126 Gaming 238 — 238 — 238 Embedded 21,055 9 21,064 8 21,072 Total $ 24,177 $ 85 $ 24,262 $ 577 $ 24,839

Intangible Assets, Goodwill a_2

Intangible Assets, Goodwill and Other (Tables)	12 Months Ended
	Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Finite-Lived Intangible Assets by Major Class	December 28, 2024 December 30, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (In millions) (In millions) Developed technology $ 13,408 $ (2,529) $ 10,879 $ 13,390 $ (1,583) $ 11,807 Customer relationships 12,324 (5,124) 7,200 12,324 (3,755) 8,569 Customer backlog 809 (809) — 809 (809) — Corporate trade name 65 (65) — 65 (65) — Product trademarks 914 (225) 689 914 (147) 767 Intangible assets subject to amortization 27,520 (8,752) 18,768 27,502 (6,359) 21,143 In-process Research and Development (IPR&D) not subject to amortization 162 — 162 220 — 220 Total acquisition-related intangible assets $ 27,682 $ (8,752) $ 18,930 $ 27,722 $ (6,359) $ 21,363
Schedule of Goodwill	December 31, 2022 Acquisitions December 30, 2023 Acquisitions December 28, (In millions) (In millions) Data Center $ 2,884 $ 58 $ 2,942 $ 461 $ 3,403 Client — 18 18 108 126 Gaming 238 — 238 — 238 Embedded 21,055 9 21,064 8 21,072 Total $ 24,177 $ 85 $ 24,262 $ 577 $ 24,839

Debt and Revolving Credit Fac_2

Debt and Revolving Credit Facility (Tables)	12 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
Schedule of Debt and Other Obligations	The Company’s total debt as of December 28, 2024 and December 30, 2023 consisted of: December 28, December 30, (In millions) 2.950% Senior Notes Due 2024 (2.950% Notes) $ — $ 750 2.375% Senior Notes Due 2030 (2.375% Notes) 750 750 3.924% Senior Notes Due 2032 (3.924% Notes) 500 500 4.393% Senior Notes Due 2052 (4.393% Notes) 500 500 Total debt (principal amount) 1,750 2,500 Unamortized debt discount and issuance costs (29) (32) Total debt (net) 1,721 2,468 Less: current portion of long-term debt and related unamortized debt premium and issuance costs — (751) Total long-term debt $ 1,721 $ 1,717
Schedule of Future Payments on Debt	As of December 28, 2024, the Company’s future debt payment obligations were as follows: Term Debt Year (In millions) 2025 - 2029 — 2030 and thereafter 1,750 Total $ 1,750

Financial Instruments (Tables)

Financial Instruments (Tables) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Schedule of Investments [Line Items]
Financial Instruments Not Recorded at Fair Value on a Recurring Basis	The carrying amounts and estimated fair values of the Company’s long-term debt are as follows: December 28, 2024 December 30, 2023 Carrying Estimated Carrying Estimated (In millions) (In millions) Current portion of long-term debt, net $ — $ — $ 751 $ 741 Long-term debt, net of current portion $ 1,721 $ 1,543 $ 1,717 $ 1,630
Fair Value, by Balance Sheet Grouping [Table Text Block]	Financial Instruments Recorded at Fair Value on a Recurring Basis December 28, 2024 December 30, 2023 (In millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Total Cash equivalents Money market funds $ 1,496 $ — $ — $ 1,496 $ 969 $ — $ 969 Corporate debt securities — 806 — 806 — 753 753 U.S. government and agency securities 130 — — 130 1,252 — 1,252 Non-U.S. government and agency securities — 116 — 116 — 135 135 Time deposits and certificates of deposits — 107 — 107 — 205 205 Short-term investments Corporate debt securities — 814 — 814 — 506 506 Time deposits and certificates of deposits — 10 — 10 — 9 9 Asset-backed and mortgage-backed securities — 28 — 28 — 34 34 U.S. government and agency securities 332 82 — 414 1,209 28 1,237 Non-U.S. government and agency securities — 79 — 79 — 54 54 Other non-current assets Time deposits and certificates of deposits — 1 — 1 — 1 1 Deferred compensation plan and other investments 197 — 25 222 133 — 133 Total assets measured at fair value $ 2,155 $ 2,043 $ 25 $ 4,223 $ 3,563 $ 1,725 $ 5,288
Investments Classified by Contractual Maturity Date	The contractual maturities of investments classified as available-for-sale are as follows: December 28, 2024 December 30, 2023 Amortized Cost Fair Value Amortized Cost Fair Value (In millions) (In millions) Due within 1 year $ 2,073 $ 2,073 $ 3,792 $ 3,792 Due in 1 year through 5 years 406 405 361 364 Due in 5 years and later 27 26 32 30 $ 2,506 $ 2,504 $ 4,185 $ 4,186
Investment Holdings, Schedule of Investments	The following is a summary of cash equivalents and short-term investments: December 28, 2024 December 30, 2023 Cost/ Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cost/ Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value (in millions) (in millions) Asset-backed and mortgage-backed securities $ 30 $ — $ (2) $ 28 $ 35 $ — $ (2) $ 33 Corporate debt securities 1,621 — (1) 1,620 1,259 — — 1,259 Money market funds 1,496 — — 1,496 969 — — 969 Time deposits and certificates of deposits 117 — — 117 214 — — 214 U.S. government and agency securities 544 — — 544 2,487 3 — 2,490 Non-U.S. government and agency securities 195 — — 195 189 — — 189 $ 4,003 $ — $ (3) $ 4,000 $ 5,153 $ 3 $ (2) $ 5,154
Fair Value, Recurring
Schedule of Investments [Line Items]
Assets, Fair Value Disclosure	$ 4,223	$ 5,288
Level 2
Schedule of Investments [Line Items]
Assets, Fair Value Disclosure	2,043	1,725
Level 1
Schedule of Investments [Line Items]
Assets, Fair Value Disclosure	2,155	3,563
Short-term Investments | Fair Value, Recurring | Commercial Paper
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	814	506
Short-term Investments | Fair Value, Recurring | Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	10	9
Short-term Investments | Level 2 | Fair Value, Recurring | Commercial Paper
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	814	506
Short-term Investments | Level 2 | Fair Value, Recurring | Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	10	9
Short-term Investments | Level 1 | Fair Value, Recurring | Commercial Paper
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Level 1 | Fair Value, Recurring | Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Other Noncurrent Assets | Fair Value, Recurring | Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	1	1
Other Noncurrent Assets | Level 2 | Fair Value, Recurring | Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	1	1
Other Noncurrent Assets | Level 1 | Fair Value, Recurring | Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	$ 0	$ 0

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Components of basic and diluted income (loss) per share	The following table sets forth the components of basic and diluted earnings per share: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions, except per share amounts) Numerator Net income for basic earnings per share $ 1,641 $ 854 $ 1,320 Denominator Basic weighted-average shares 1,620 1,614 1,561 Effect of potentially dilutive shares from employee equity plans 17 11 10 Diluted weighted-average shares 1,637 1,625 1,571 Earnings per share: Basic $ 1.01 $ 0.53 $ 0.85 Diluted $ 1.00 $ 0.53 $ 0.84

Common Stock and Stock-Based _2

Common Stock and Stock-Based Incentive Compensation Plans (Tables)	12 Months Ended
	Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Common Shares Outstanding	Shares of common stock outstanding were as follows: Year Ended December 28, December 30, December 31, (In millions) Balance, beginning of period 1,616 1,612 1,207 Common stock issued in the acquisition of Xilinx — — 429 Common stock issued under employee equity plans 17 17 17 Repurchases of common stock (6) (10) (36) Common stock repurchases for tax withholding on equity awards (5) (4) (5) Issuance of common stock upon warrant exercise — 1 — Balance, end of period 1,622 1,616 1,612
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	Stock-based compensation expense was allocated in the Company’s Consolidated Statements of Operations as follows: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Cost of sales $ 21 $ 30 $ 29 Research and development 1,079 1,002 697 Marketing, general, and administrative 307 352 355 Total stock-based compensation expense before income taxes 1,407 1,384 1,081 Income tax benefit (251) (249) (179) Total stock-based compensation expense, net of income taxes $ 1,156 $ 1,135 $ 902
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The weighted-average estimated fair value of employee stock options granted during 2024, 2023 and 2022 was $68.38, $53.72 and $44.35 per share, respectively, using the following assumptions: December 28, 2024 December 30, 2023 December 31, 2022 Expected volatility 54.34 % 52.36% - 52.42% 51.28 % Risk-free interest rate 3.80 % 3.93% - 4.11% 3.00 % Expected dividends — % — % — % Expected life (in years) 4.98 4.96 - 5.04 4.75 December 28, 2024 December 30, 2023 December 31, 2022 Expected volatility 52.68% - 53.19% 51.12% - 56.22% 50.65% - 53.51% Risk-free interest rate 3.82% - 4.41% 4.30% - 4.36% 1.14%- 3.17% Expected dividends — % — % — % Expected term (in years) 2.48 - 3.00 2.17 - 3.00 2.07 - 3.07
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes stock option activity and related information: Outstanding Number Weighted- Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life (In millions, except share price) Balance as of December 30, 2023 3 $ 68.33 Granted — $ 134.27 Forfeited — $ 102.71 Exercised (1) $ 22.17 Balance as of December 28, 2024 2 $ 89.73 $ 81 3.92 Exercisable December 28, 2024 1 $ 74.61 $ 69 2.83
Schedule of Share-based Compensation, Restricted Stock Units, Activity	The following table summarizes time-based RSU activity and related information: Number Weighted- Average Grant Date Fair Value (In millions) Unvested shares as of December 30, 2023 32 $ 100.65 Granted 12 $ 141.95 Forfeited (1) $ 107.96 Vested (13) $ 101.35 Unvested shares as of December 28, 2024 30 $ 116.77
Schedule of Nonvested Performance-based Units Activity	The following table summarizes PRSU activity and related information: Number Weighted-Average (In millions) Unvested shares as of December 30, 2023 2 $ 117.65 Granted 1 $ 118.98 Forfeited — $ 132.80 Vested (1) $ 91.15 Unvested shares as of December 28, 2024 2 $ 139.31
Schedule of ESPP	The weighted-average grant date fair value for the ESPP during 2024, 2023 and 2022 was $43.80, $31.11 and $24.71 per share, respectively, using the following assumptions: December 28, 2024 December 30, 2023 December 31, 2022 Expected volatility 48.14% - 49.38% 45.74% - 49.40% 58.15% - 63.76% Risk-free interest rate 4.42% - 5.41% 5.13% - 5.46% 1.43% - 4.52% Expected dividends — % — % — % Expected term (in years) 0.50 0.50 0.50

Restructuring and Related Act_2

Restructuring and Related Activities (Tables)	12 Months Ended
	Dec. 28, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost	Employee severance and benefits Asset impairment Total (in millions) Liability as of December 30, 2023 $ — $ — $ — Current period costs 113 73 186 Cash payments (24) — (24) Non-cash charges — (73) (73) Liability as of December 28, 2024 $ 89 $ — $ 89

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 28, 2024
Income Tax Disclosure [Abstract]
Schedule of Loss before Income Tax	Income before income taxes consists of the following: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) U.S. $ 2,369 $ 454 $ 2,093 Non-U.S. (347) 54 (895) Total pre-tax income including equity income in investee $ 2,022 $ 508 $ 1,198
Provision (Benefit) for Income Taxes	The income tax provision (benefit) consists of: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Current: U.S. federal $ 1,338 $ 496 $ 1,191 U.S. state and local 64 27 31 Non-U.S. 142 150 161 Total 1,544 673 1,383 Deferred: U.S. federal (311) (860) (1,365) U.S. state and local 6 (29) (26) Non-U.S. (858) (130) (114) Total (1,163) (1,019) (1,505) Income tax provision (benefit) $ 381 $ (346) $ (122)
Schedule of Effective Income Tax Rate Reconciliation	The table below displays the reconciliation between statutory federal income taxes and the total income tax provision (benefit). Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Statutory federal income tax expense at 21% $ 425 $ 107 $ 252 Tax effect from intercompany integration transaction 373 — — Foreign rate detriment (benefit) 153 (11) 195 Interest and penalty 136 53 33 State income taxes, net of federal benefit 22 (2) (3) Foreign-Derived Intangible Income (FDII) deduction (275) (185) (261) Research credits (232) (169) (241) GILTI and other foreign inclusion (133) (138) (96) Stock-based and non-deductible compensation (101) (17) (6) Other 13 16 5 Income tax provision (benefit) $ 381 $ (346) $ (122)
Schedule of Deferred Tax Assets and Liabilities	Deferred income taxes reflect the net tax effects of tax carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the balances for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of December 28, 2024 and December 30, 2023 were as follows: December 28, December 30, (In millions) Deferred tax assets: Capitalized R&D $ 2,892 $ 1,753 Net operating loss carryovers 962 992 Accruals and reserves not currently deductible 829 574 Federal and state tax credit carryovers 679 660 Foreign R&D and investment tax credits 579 597 Employee benefits not currently deductible 334 302 Lease liability 182 181 Foreign tax credits 77 71 Other 111 96 Total deferred tax assets 6,645 5,226 Less: valuation allowance (2,136) (2,124) Total deferred tax assets, net of valuation allowance 4,509 3,102 Deferred tax liabilities: Acquired intangibles (3,614) (3,104) GILTI (222) (524) Right-of-use assets (182) (175) Other (152) (135) Total deferred tax liabilities (4,170) (3,938) Net deferred tax assets (liabilities) $ 339 $ (836) During 2024, the Company executed an intercompany integration transaction and remeasured associated deferred taxes, resulting in increases to the deferred tax liability for acquisition-related intangibles and the deferred tax asset for Capitalized R&D, partially offset by a decrease in the deferred tax liability for GILTI. The movement in the deferred tax valuation allowance was as follows: December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Balance at beginning of year $ 2,124 $ 2,078 $ 1,735 Charges to income tax expense and other accounts 9 41 112 Acquisition-related 3 5 231 Balance at end of year $ 2,136 $ 2,124 $ 2,078
Schedule of Unrecognized Tax Benefits Roll Forward	reconciliation of the Company's gross unrecognized tax benefits was as follows: December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Balance at beginning of year $ 1,463 $ 1,361 $ 275 Increases for tax positions taken in the current year 57 53 748 Increases for tax positions taken in prior years 24 57 104 Decreases for tax positions taken in prior years (18) (8) (12) Increases to tax positions taken in prior years through acquisitions — — 252 Decreases for settlements with taxing authorities and statute of limitation lapses (28) — (6) Balance at end of year $ 1,498 $ 1,463 $ 1,361

Other Expense, Net (Tables)

Other Expense, Net (Tables)	12 Months Ended
	Dec. 28, 2024
Income Statement Related Disclosures [Abstract]
Schedule of Other Expense, Net	The following table summarizes the components of Other income (expense), net: Year Ended December 28, 2024 December 30, 2023 December 31, 2022 (In millions) Interest income $ 182 $ 206 $ 65 Gains (losses) on equity investments, net 2 (1) (62) Other income (expense) (3) (8) 5 Other income (expense), net $ 181 $ 197 $ 8

Commitments and Guarantees (Tab

Commitments and Guarantees (Tables)	12 Months Ended
	Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Leases, Supplemental Cash Flows	Supplemental information related to leases is as follows: December 28, 2024 Weighted-average remaining lease term in years – operating leases 7.28 Weighted-average discount rate – operating leases 4.63 %
Operating Lease, Liability, Maturity	Future minimum lease payments under non-cancellable operating lease liabilities as of December 28, 2024 are as follows: Year (In millions) 2025 $ 134 2026 135 2027 94 2028 66 2029 60 2030 and thereafter 235 Total minimum lease payments 724 Less: interest (124) Present value of net minimum lease payments 600 Less: current portion (109) Total long-term operating lease liabilities $ 491
Schedule of Future Unconditional Purchase Obligations	Total future unconditional purchase commitments as of December 28, 2024 were as follows: Year (In millions) 2025 $ 4,501 2026 274 2027 46 2028 46 2029 45 2030 and thereafter 56 Total unconditional purchase commitments $ 4,968 On an ongoing basis, the Company works with suppliers on the timing of payments and deliveries of purchase commitments, taking into account business conditions.
Schedule of Product Warranty Liability	Changes in the Company’s estimated liability for product warranty during 2024 and 2023 are as follows: December 28, December 30, (In millions) Beginning balance $ 85 $ 65 Provisions during the period 213 126 Settlements during the period (110) (106) Ending balance $ 188 $ 85

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Marketing, communications and advertising expenses	$ 1,200	$ 695	$ 683
Prior Period Reclassification Adjustment		$ 1,100
Transferred over Time [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total revenue recognized over time	8%	25%	24%
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Customer payment due, standard contractual term	30 days
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Customer payment due, standard contractual term	60 days

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information - Schedule of Inventory, Current (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 351	$ 279
Work in process	4,289	3,260
Finished goods	1,094	812
Inventories	$ 5,734	$ 4,351

Supplemental Balance Sheet In_4

Supplemental Balance Sheet Information - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Unbilled accounts receivables	$ 628	$ 1,053
Other current assets	1,250	1,259
Prepaid expenses and other current assets	$ 1,878	$ 2,312

Supplemental Balance Sheet In_5

Supplemental Balance Sheet Information - Property and Equipment, net (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Land, building and leasehold improvements	$ 853	$ 821
Equipment	2,798	2,346
Construction in progress	324	209
Property and equipment, gross	3,975	3,376
Accumulated depreciation	(2,173)	(1,787)
Property and equipment, net	$ 1,802	$ 1,589

Supplemental Balance Sheet In_6

Supplemental Balance Sheet Information - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation	$ 454	$ 441	$ 439

Supplemental Balance Sheet In_7

Supplemental Balance Sheet Information - Schedule of Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation and benefits	$ 1,063	$ 827
Accrued marketing programs	1,174	884
Customer program liabilities	1,349	788
Other accrued and current liabilities	674	583
Accrued liabilities	$ 4,260	$ 3,082

Supplemental Balance Sheet In_8

Supplemental Balance Sheet Information Remaining Performance Obligations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue allocated to remaining performance obligations that are unsatisfied or partially unsatisfied	$ 85
RevenueRemainingPerformanceObligation12months	$ 67
Transferred over Time [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Total revenue recognized over time	8%	25%	24%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-12-25
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction, period	12 months

Segment Reporting - Summary of

Segment Reporting - Summary of Operations by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting Information
Net revenue	$ 25,785	$ 22,680	$ 23,601
Segment Reporting, Other Segment Item, Amount	23,885	22,279	22,337
Operating income	1,900	401	1,264
Client
Segment Reporting Information
Net revenue	7,054	4,651	6,201
Datacenter
Segment Reporting Information
Net revenue	12,579	6,496	6,043
Gaming
Segment Reporting Information
Net revenue	2,595	6,212	6,805
Embedded
Segment Reporting Information
Net revenue	3,557	5,321	4,552
Operating Segments
Segment Reporting Information
Operating income	(4,190)	(4,419)	(4,979)
Operating Segments | Client
Segment Reporting Information
Segment Reporting, Other Segment Item, Amount	6,157	4,697	5,011
Operating income	897	(46)	1,190
Operating Segments | Datacenter
Segment Reporting Information
Segment Reporting, Other Segment Item, Amount	9,097	5,229	4,195
Operating income	3,482	1,267	1,848
Operating Segments | Gaming
Segment Reporting Information
Segment Reporting, Other Segment Item, Amount	2,305	5,241	5,852
Operating income	290	971	953
Operating Segments | Embedded
Segment Reporting Information
Segment Reporting, Other Segment Item, Amount	2,136	2,693	2,300
Operating income	1,421	2,628	2,252
Operating Segments | All Other
Segment Reporting Information
Segment Reporting, Other Segment Item, Amount	4,190	4,419	4,979
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Segment Reporting Information
Operating income	$ 4,190	$ 4,419	$ 4,979

Segment Reporting - Components

Segment Reporting - Components of Other Operating Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting Information
Total stock-based compensation expense before income taxes	$ (1,407)	$ (1,384)	$ (1,081)
Restructuring charges	(186)	0	0
Inventory loss at contract manufacturer	(65)	0	0
Operating income related to licensed IP	48	34	102
Operating income	1,900	401	1,264
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Segment Reporting Information
Amortization of acquisition-related intangibles	2,394	2,811	3,548
Total stock-based compensation expense before income taxes	1,407	1,384	1,081
Acquisition-related and other costs	186	258	452
Restructuring charges	186	0	0
Inventory loss at contract manufacturer	65	0
Operating income related to licensed IP	(48)	(34)	(102)
Operating income	$ 4,190	$ 4,419	$ 4,979

Segment Reporting - External Cu

Segment Reporting - External Customers by Geographic Region (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting Information
Net revenue	$ 25,785	$ 22,680	$ 23,601
UNITED STATES
Segment Reporting Information
Net revenue	8,693	7,837	8,049
CHINA
Segment Reporting Information
Net revenue	6,231	3,417	5,207
China (including Hong Kong)
Segment Reporting Information
Net revenue	1,767	4,629	4,177
Japan
Segment Reporting Information
Net revenue	1,625	2,030	1,773
Europe
Segment Reporting Information
Net revenue	3,301	1,841	2,369
SINGAPORE
Segment Reporting Information
Net revenue	3,614	2,231	1,380
Other Countries [Member]
Segment Reporting Information
Net revenue	$ 554	$ 695	$ 646

Segment Reporting - Sales by Cu

Segment Reporting - Sales by Customer (Details)	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Sales to major customers | Customer Concentration Risk | Customer A
Segment Reporting Information
Concentration risk percentage	18%	16%

Segment Reporting - Property an

Segment Reporting - Property and Equipment, Net by Geographic Region (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Segment Reporting Information
Property and equipment, net	$ 1,802	$ 1,589
UNITED STATES
Segment Reporting Information
Property and equipment, net	1,312	1,143
CANADA
Segment Reporting Information
Property and equipment, net	104	84
CHINA
Segment Reporting Information
Property and equipment, net	38	42
SINGAPORE
Segment Reporting Information
Property and equipment, net	140	144
Other Countries [Member]
Segment Reporting Information
Property and equipment, net	62	44
INDIA
Segment Reporting Information
Property and equipment, net	100	86
IRELAND
Segment Reporting Information
Property and equipment, net	$ 46	$ 46

Business Combinations and Ass_3

Business Combinations and Asset Acquisitions (Details) - USD ($) $ in Millions			12 Months Ended
	May 26, 2022	Feb. 14, 2022	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022	Dec. 25, 2021
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Cash Acquired from Acquisition					$ 2,366
Goodwill			$ 24,839	$ 24,262	24,177
Asset Acquisition [Line Items]
Cash Acquired from Acquisition					2,366
Goodwill			24,839	24,262	24,177
Business Acquisition, Pro Forma Revenue					24,117
Business Acquisition, Pro Forma Net Income (Loss)					2,311
Finite-Lived Intangible Assets, Gross			27,520	27,502
Finite-Lived Intangible Assets, Accumulated Amortization			(8,752)	(6,359)
Finite-Lived Intangible Assets, Net			18,768	21,143
Acquisition-related intangibles			18,930	21,363
Intangible Assets, Gross (Excluding Goodwill)			27,682	27,722
Finite-Lived Intangible Asset, Expected Amortization, Year One			2,225
Finite-Lived Intangible Asset, Expected Amortization, Year Two			2,111
Finite-Lived Intangible Asset, Expected Amortization, Year Three			1,993
Finite-Lived Intangible Asset, Expected Amortization, Year Four			1,885
Finite-Lived Intangible Asset, Expected Amortization, Year Five			1,659
Finite-Lived Intangible Asset, Expected Amortization, after Year Five			8,895
Goodwill, Acquired During Period			577	85
Cash and cash equivalents			3,787	3,933	4,835
Total cash, cash equivalents, and restricted cash			3,811	3,933	4,835	$ 2,535
Restricted cash included in Prepaid expense and other current assets			24	0	0
Stock Issued			0	0	48,514
Termination Fee Merger Agreement			300
Datacenter
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Goodwill			3,403	2,942	2,884
Asset Acquisition [Line Items]
Goodwill			3,403	2,942	2,884
Goodwill, Acquired During Period			461	58
Gaming
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Goodwill			238	238	238
Asset Acquisition [Line Items]
Goodwill			238	238	238
Goodwill, Acquired During Period			0	0
Embedded
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Goodwill			21,072	21,064	21,055
Asset Acquisition [Line Items]
Goodwill			21,072	21,064	21,055
Goodwill, Acquired During Period			8	9
Client
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Goodwill			126	18	0
Asset Acquisition [Line Items]
Goodwill			126	18	0
Goodwill, Acquired During Period			108	18
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Asset Acquisition [Line Items]
Acquisition-related and other costs			(186)	(258)	(452)
Other Intangible Assets
Asset Acquisition [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)			162	220
Developed Technology Rights
Asset Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross			13,408	13,390
Finite-Lived Intangible Assets, Accumulated Amortization			(2,529)	(1,583)
Finite-Lived Intangible Assets, Net			10,879	11,807
Customer Relationships
Asset Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross			12,324	12,324
Finite-Lived Intangible Assets, Accumulated Amortization			(5,124)	(3,755)
Finite-Lived Intangible Assets, Net			7,200	8,569
Customer Contracts
Asset Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross			809	809
Finite-Lived Intangible Assets, Accumulated Amortization			(809)	(809)
Finite-Lived Intangible Assets, Net			0	0
Trademarks
Asset Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross			914	914
Finite-Lived Intangible Assets, Accumulated Amortization			(225)	(147)
Finite-Lived Intangible Assets, Net			689	767
Trade Names
Asset Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross			65	65
Finite-Lived Intangible Assets, Accumulated Amortization			(65)	(65)
Finite-Lived Intangible Assets, Net			0	0
Pensando
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Transaction value	$ 1,900
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets					208
Goodwill			1,100
Asset Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles					349
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets					208
Goodwill			1,100
Consideration transferred	1,700
Transaction value	1,900
Pensando | Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Asset Acquisition [Line Items]
Acquisition-related and other costs				190	102
Xilinx, Inc. [Member]
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Cash Acquired from Acquisition		$ 2,400	0	0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities					1,300
Goodwill		22,800
Asset Acquisition [Line Items]
Cash Acquired from Acquisition		2,400	0	0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles					27,300
Payments to Acquire Businesses, Net of Cash Acquired		46,400
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities					1,300
Goodwill		$ 22,800
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual				4,612
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual				2,247
Consideration transferred	$ 48,800
Xilinx, Inc. [Member] | Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Asset Acquisition [Line Items]
Acquisition-related and other costs				26	$ 350
Other Acquisitions
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Transaction value				134
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net				49
Goodwill				85
Asset Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net				49
Goodwill				85
Transaction value				$ 134
Silo AI
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities			43
Goodwill			577
Asset Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			19
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities			43
Goodwill			577
Consideration transferred			$ 553
ZT Systems
Asset Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			8,335,852
Business Combination, Shares Issuable Contingent			740,964
Business Combination, Price of Acquisition, Expected			$ 3,400
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 300
Business Combination, Shares Issuable Contingent			740,964
Business Combination, Price of Acquisition, Expected			$ 3,400
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 300

Intangible Assets, Goodwill a_3

Intangible Assets, Goodwill and Other (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 2,400	$ 2,800
Amortization of operating lease right-of-use assets	2,393	$ 2,811	$ 3,548
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)	$ 58
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Income (Loss)

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Goodwill [Line Items]
Goodwill	$ 24,839	$ 24,262	$ 24,177

Related Parties - Equity Join_2

Related Parties - Equity Joint Ventures (Details) $ in Millions	12 Months Ended
	Dec. 28, 2024 USD ($) joint_venture	Dec. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Schedule of Equity Method Investments [Line Items]
Purchases from related party	$ 1,700
Equity income in investee	33	$ 16	$ 14
Equity method investment	149	99
Operating income related to licensed IP	48	34	102
ATMP JV
Schedule of Equity Method Investments [Line Items]
Loans and Leases Receivable, Related Parties	100
Loans and Leases Receivable, Related Parties	100
ATMP JV
Schedule of Equity Method Investments [Line Items]
Equity method investment	$ 149	99
Equity Method Investment, Additional Information	17 million
Equity Method Investment, Additional Information	17 million
Joint Venture | THATIC JV
Schedule of Equity Method Investments [Line Items]
Estimated license fees earned over time	$ 48	34
Joint Venture | ATMP JV
Schedule of Equity Method Investments [Line Items]
Equity interest in each JV	15%
Number of joint ventures | joint_venture	2
Receivables - related parties	$ 12
Equity income in investee	33	16	$ 14
Accounts Payable	476	363
Resale to ATMP JV	$ 121	14
Joint Venture | THATIC JV
Schedule of Equity Method Investments [Line Items]
Number of joint ventures | joint_venture	2
Receivables - related parties	$ 0	$ 9

Debt and Revolving Credit Fac_3

Debt and Revolving Credit Facility -Summary of Debt and Other Obligations (Details) - USD ($)	Dec. 28, 2024	Dec. 30, 2023
Debt Instrument [Line Items]
Total debt	$ (1,750,000,000)
Unamortized debt discount and issuance costs	(29,000,000)	$ (32,000,000)
Total debt (net)	1,721,000,000	2,468,000,000
Less: current portion of long-term debt and related unamortized debt premium and issuance costs	0	(751,000,000)
Long-term debt, net of current portion	1,721,000,000	1,717,000,000
principle balance due
Debt Instrument [Line Items]
Total debt	$ (1,750,000,000)	(2,500,000,000)
Senior Notes | 2.950% Senior Notes Due 2024
Debt Instrument [Line Items]
Interest rate, stated percentage	2.95%
Total debt	$ 0	(750,000,000)
Senior Notes | 2.375% Senior Notes Due 2030
Debt Instrument [Line Items]
Total debt	$ (750,000,000)	(750,000,000)
Senior Notes | 3.924% Senior Note due 2032
Debt Instrument [Line Items]
Interest rate, stated percentage	3.924%
Total debt	$ (500,000,000)	(500,000,000)
Senior Notes | 4.393% Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage	4.393%
Total debt	$ (500,000,000)	$ (500,000,000)
Senior Notes | 2.375% Senior Note due 2030
Debt Instrument [Line Items]
Interest rate, stated percentage	2.375%

Debt and Revolving Credit Fac_4

Debt and Revolving Credit Facility - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022	Feb. 14, 2022
Debt Instrument [Line Items]
Total	$ 1,750,000,000
Repayment of debt	$ 750,000,000	$ 0	$ 312,000,000
principal balance of notes assumed
Debt Instrument [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt				$ 1,500,000,000
3.924% Senior Note due 2032 | Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage	3.924%
Total	$ 500,000,000	500,000,000
4.393% Senior Notes | Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage	4.393%
Total	$ 500,000,000	$ 500,000,000
Line of Credit
Debt Instrument [Line Items]
Secured revolving line of credit, maximum borrowing capacity	3,000,000,000
Line of Credit Facility, Maximum Month-end Outstanding Amount	0
Line of Credit Facility, Maximum Month-end Outstanding Amount	0
Commercial Paper
Debt Instrument [Line Items]
Secured revolving line of credit, maximum borrowing capacity	3,000,000,000
Line of Credit Facility, Maximum Month-end Outstanding Amount	0
Line of Credit Facility, Maximum Month-end Outstanding Amount	$ 0

Debt and Revolving Credit Fac_5

Debt and Revolving Credit Facility - Future Payments on Total Debt (Details) $ in Millions	Dec. 28, 2024 USD ($)
Debt Disclosure [Abstract]
2030 and thereafter	$ 1,750
Total	1,750
2023	$ 0

Financial Instruments - Narrati

Financial Instruments - Narrative (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Schedule of Investments [Line Items]
Equity Securities without Readily Determinable Fair Value, Amount	$ 468	$ 155
Debt Securities, Available-for-Sale, Amortized Cost	4,003	5,153
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	3
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(3)	(2)
Debt Securities, Available-for-Sale	4,000	5,154
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost	2,073	3,792
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost	406	361
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value	2,073	3,792
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value	405	364
Debt Securities, Available-for-sale, maturity, allocated and single maturity date, rolling after five years, fair value	26	30
Debt Security, Available-for-sale, Maturity, Allocated and Single maturity date, rolling after five years, amortized cost	27	32
Asset-Backed Securities
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	30	35
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(2)	(2)
Debt Securities, Available-for-Sale	28	33
Commercial Paper
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	1,621	1,259
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(1)	0
Debt Securities, Available-for-Sale	1,620	1,259
Government money Market Funds
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	1,496	969
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	1,496	969
Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	117	214
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	117	214
US Government Agencies Debt Securities
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	544	2,487
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	3
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	544	2,490
Foreign Government Debt
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	195	189
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	195	189
Fair Value, Recurring
Schedule of Investments [Line Items]
Assets, Fair Value Disclosure	4,223	5,288
Level 1
Schedule of Investments [Line Items]
Assets, Fair Value Disclosure	2,155	3,563
Level 2
Schedule of Investments [Line Items]
Assets, Fair Value Disclosure	2,043	1,725
Cash Equivalents | Government money Market Funds | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	1,496	969
Cash Equivalents | Government money Market Funds | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	1,496	969
Cash Equivalents | Government money Market Funds | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash Equivalents | Commercial Paper | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	806	753
Cash Equivalents | Commercial Paper | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash Equivalents | Commercial Paper | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	806	753
Cash Equivalents | Bank Time Deposits [Member] | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	107	205
Cash Equivalents | Bank Time Deposits [Member] | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash Equivalents | Bank Time Deposits [Member] | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	107	205
Short-term Investments
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	2,506	4,185
Debt Securities, Available-for-Sale	2,504	4,186
Short-term Investments | Commercial Paper | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	814	506
Short-term Investments | Commercial Paper | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Commercial Paper | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	814	506
Short-term Investments | Bank Time Deposits [Member] | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	10	9
Short-term Investments | Bank Time Deposits [Member] | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Bank Time Deposits [Member] | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	10	9
Short-term Investments | Asset-Backed Securities | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	28	34
Short-term Investments | Asset-Backed Securities | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Asset-Backed Securities | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	28	34
Short-term Investments | US Government Agencies Debt Securities | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	414	1,237
Short-term Investments | US Government Agencies Debt Securities | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	332	1,209
Short-term Investments | US Government Agencies Debt Securities | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	82	28
Other Noncurrent Assets | Bank Time Deposits [Member] | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	1	1
Other Noncurrent Assets | Bank Time Deposits [Member] | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Other Noncurrent Assets | Bank Time Deposits [Member] | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	1	1
Other Noncurrent Assets | Fair Value MeasurementsRecurring Def Comp | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	222	133
Other Noncurrent Assets | Fair Value MeasurementsRecurring Def Comp | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	197	133
Other Noncurrent Assets | Fair Value MeasurementsRecurring Def Comp | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Investments, Fair Value Disclosure	0	0
Cash and Cash Equivalents | US Government Agencies Debt Securities | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	130	1,252
Cash and Cash Equivalents | US Government Agencies Debt Securities | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	130	1,252
Cash and Cash Equivalents | US Government Agencies Debt Securities | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0
Cash and Cash Equivalents | Foreign Government Short-Term Debt Securities | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	116	135
Cash and Cash Equivalents | Foreign Government Short-Term Debt Securities | Level 1 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash and Cash Equivalents | Foreign Government Short-Term Debt Securities | Level 2 | Fair Value, Recurring
Schedule of Investments [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	116	135
Foreign Currency Forward Contracts | Designated as Hedging Instrument
Schedule of Investments [Line Items]
Derivative, notional amount	2,200	2,400
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets
Schedule of Investments [Line Items]
Derivative Asset, Subject to Master Netting Arrangement, before Offset	6	24
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Accrued Liabilities
Schedule of Investments [Line Items]
Derivative Asset, Subject to Master Netting Arrangement, before Offset	60	18
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Other Noncurrent Liabilities
Schedule of Investments [Line Items]
Derivative Asset, Subject to Master Netting Arrangement, before Offset	11
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument
Schedule of Investments [Line Items]
Derivative, notional amount	$ 642	$ 568

Financial Instruments - Schedul

Financial Instruments - Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments not Recorded at Fair Value (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost	$ 2,073	$ 3,792
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value	2,073	3,792
Debt Securities, Available-for-Sale, Amortized Cost	4,003	5,153
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	3
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(3)	(2)
Debt Securities, Available-for-Sale	4,000	5,154
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost	406	361
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value	405	364
Debt Security, Available-for-sale, Maturity, Allocated and Single maturity date, rolling after five years, amortized cost	27	32
Debt Securities, Available-for-sale, maturity, allocated and single maturity date, rolling after five years, fair value	26	30
Equity Securities without Readily Determinable Fair Value, Amount	468	155
Equity Securities without Readily Determinable Fair Value, Amount	468	155
Short-term Investments
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	2,506	4,185
Debt Securities, Available-for-Sale	2,504	4,186
Carrying Amount
Summary of Investment Holdings [Line Items]
Short-term debt	0	751
Level 2 | Estimated Fair Value
Summary of Investment Holdings [Line Items]
Short-term debt	0	741
Government money Market Funds
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	1,496	969
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	1,496	969
Commercial Paper
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	1,621	1,259
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(1)	0
Debt Securities, Available-for-Sale	1,620	1,259
US Government Agencies Debt Securities
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	544	2,487
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	3
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	544	2,490
Bank Time Deposits [Member]
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	117	214
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	117	214
Asset-Backed Securities
Schedule of Investments [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	30	35
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(2)	(2)
Debt Securities, Available-for-Sale	$ 28	$ 33

Financial Instruments - Cash, C

Financial Instruments - Cash, Cash Equivalents, and Marketable Securities Fair Value Measurements (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 4,223	$ 5,288
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	2,155	3,563
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	2,043	1,725
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	25
Cash and Cash Equivalents | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	130	1,252
Cash and Cash Equivalents | Fair Value, Recurring | Foreign Government Short-Term Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	116	135
Cash and Cash Equivalents | Level 1 | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	130	1,252
Cash and Cash Equivalents | Level 1 | Fair Value, Recurring | Foreign Government Short-Term Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash and Cash Equivalents | Level 2 | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0
Cash and Cash Equivalents | Level 2 | Fair Value, Recurring | Foreign Government Short-Term Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	116	135
Cash and Cash Equivalents | Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash and Cash Equivalents | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Foreign Government Short-Term Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0
Short-term Investments | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	814	506
Short-term Investments | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	414	1,237
Short-term Investments | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	10	9
Short-term Investments | Fair Value, Recurring | Asset-Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	28	34
Short-term Investments | Fair Value, Recurring | Foreign Government Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	79	54
Short-term Investments | Level 1 | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Level 1 | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	332	1,209
Short-term Investments | Level 1 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Level 1 | Fair Value, Recurring | Asset-Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Level 1 | Fair Value, Recurring | Foreign Government Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Short-term Investments | Level 2 | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	814	506
Short-term Investments | Level 2 | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	82	28
Short-term Investments | Level 2 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	10	9
Short-term Investments | Level 2 | Fair Value, Recurring | Asset-Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	28	34
Short-term Investments | Level 2 | Fair Value, Recurring | Foreign Government Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	79	54
Short-term Investments | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Short-term Investments | Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government Agencies Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Short-term Investments | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Short-term Investments | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Asset-Backed Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Short-term Investments | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Foreign Government Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Other Noncurrent Assets | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1	1
Other Noncurrent Assets | Fair Value, Recurring | Fair Value MeasurementsRecurring Def Comp
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	222	133
Other Noncurrent Assets | Level 1 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Other Noncurrent Assets | Level 1 | Fair Value, Recurring | Fair Value MeasurementsRecurring Def Comp
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	197	133
Other Noncurrent Assets | Level 2 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1	1
Other Noncurrent Assets | Level 2 | Fair Value, Recurring | Fair Value MeasurementsRecurring Def Comp
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Other Noncurrent Assets | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Other Noncurrent Assets | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Fair Value MeasurementsRecurring Def Comp
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	25
Cash Equivalents | Fair Value, Recurring | Government money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	1,496	969
Cash Equivalents | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	806	753
Cash Equivalents | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	107	205
Cash Equivalents | Level 1 | Fair Value, Recurring | Government money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	1,496	969
Cash Equivalents | Level 1 | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash Equivalents | Level 1 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash Equivalents | Level 2 | Fair Value, Recurring | Government money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Cash Equivalents | Level 2 | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	806	753
Cash Equivalents | Level 2 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	107	205
Cash Equivalents | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Government money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0
Cash Equivalents | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Commercial Paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0
Cash Equivalents | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Bank Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0
Foreign Currency Forward Contracts | Designated as Hedging Instrument
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	2,200	2,400
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	$ 642	$ 568

Financial Instruments - Financi

Financial Instruments - Financial Instruments Not Recorded at Fair value (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Carrying Amount
Schedule of Investments [Line Items]
Long-term debt, net	$ 1,721	$ 1,717
Short-term debt	0	751
Estimated Fair Value
Schedule of Investments [Line Items]
Long-term debt, net	1,543	1,630
Estimated Fair Value | Level 2
Schedule of Investments [Line Items]
Short-term debt	$ 0	$ 741

Concentrations of Credit and _2

Concentrations of Credit and Operation Risk (Details)	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Top Customer One | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	24%	16%

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	$ 55,892	$ 54,750
Ending balance	57,568	55,892	$ 54,750
Accumulated other comprehensive loss
Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(10)	(41)	(3)
Total other comprehensive income (loss)	(59)	31	(38)
Ending balance	$ (69)	$ (10)	$ (41)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1	6	16
Numerator
Numerator	$ 1,641	$ 854	$ 1,320
Denominator
Denominator for basic earnings per share (in shares)	1,620	1,614	1,561
Employee equity plans and warrants (in shares)	17	11	10

Common Stock and Stock-Based _3

Common Stock and Stock-Based Incentive Compensation Plans - Common Stock Activities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	1,663,000,000
Stock Repurchased During Period, Shares	(5,900,000)
Repurchases of common stock	$ 862
Balance, end of period (in shares)	1,680,000,000	1,663,000,000
Share Repurchase Program, Authorized, Amount	$ 12,000
Common stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	1,616,000,000	1,612,000,000	1,207,000,000
Common stock issued under employee equity incentive plans, net of tax withholding (in shares)	17,000,000	17,000,000	17,000,000
Stock Repurchased During Period, Shares	(6,000,000)	(10,000,000)	(36,000,000)
Common stock repurchases for tax withholding on equity awards (in shares)	(5,000,000)	(4,000,000)	(5,000,000)
Balance, end of period (in shares)	1,622,000,000	1,616,000,000	1,612,000,000
Issuance of common stock upon warrant exercise, shares	0	1,000,000	0
Common stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock Issued During Period, Shares, Acquisitions	0	0	429,000,000

Common Stock and Stock-Based _4

Common Stock and Stock-Based Incentive Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (shares)	87,645,874
Share Repurchase Program, Remaining Authorized, Amount	$ 4,700
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Expiration period	7 years
Purchase price of common stock	100%
Stock options, shares granted, weighted average estimated grant date fair value per share (USD per share)	$ 68.38	$ 53.72	$ 44.35
Stock options, shares exercised, total intrinsic value	$ 86	$ 173	$ 139
Unrecognized compensation expense	$ 41
Weighted-average remaining recognition period (in years)	2 years 8 months 15 days
Time Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 2,600
Weighted-average remaining recognition period (in years)	2 years 7 months 17 days
Weighted Average Grant Date Fair Value (USD per share)	$ 141.95	$ 106.28	$ 92.92
Restricted stock units, shares vested, total fair value	$ 2,000	$ 1,100	$ 889
Weighted-average grant date fair value (usd per share)	$ 116.77	$ 100.65
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining recognition period (in years)	1 year 7 months 9 days
Weighted Average Grant Date Fair Value (USD per share)	$ 118.98	$ 134.87	$ 121.12
Restricted stock units, shares vested, total fair value	$ 226	$ 100	$ 254
Weighted-average grant date fair value (usd per share)	$ 139.31	$ 117.65
Total unrecognized compensation expense	$ 154
Performance Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of target shares granted	0%
Performance Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of target shares granted	250%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock	85%
Maximum percent of earnings withheld during offering period	15%
Weighted-average remaining recognition period (in years)	4 months 13 days
Weighted-average grant date fair value (usd per share)	$ 43.80	$ 31.11	$ 24.71
Share-based compensation, common stock purchased (in shares)	2,000,000
Weighted average purchase price (USD per share)	$ 111
Aggregate cash proceeds	$ 265
Offering period	6 months
Common stock | 2004 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (shares)	60,000,000
Shares available for issuance (shares)	34,000,000

Common Stock and Stock-Based _5

Common Stock and Stock-Based Incentive Compensation Plans - Allocation of Recognized Period Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense before income taxes	$ 1,407	$ 1,384	$ 1,081
Income tax benefit	(251)	(249)	(179)
Total stock-based compensation expense, net of income taxes	1,156	1,135	902
Cost of sales
Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense before income taxes	21	30	29
Research and development
Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense before income taxes	1,079	1,002	697
Marketing, general, and administrative
Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense before income taxes	$ 307	$ 352	$ 355

Common Stock and Stock-Based _6

Common Stock and Stock-Based Incentive Compensation Plans - Stock Option Valuation Assumptions (Details)	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	54.34%		51.28%
Risk-free interest rate	3.80%		3%
Expected dividends	0%	0%	0%
Expected life (in years)	4 years 11 months 23 days		4 years 9 months
PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividends	0%	0%	0%
Minimum | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	52.36%
Risk-free interest rate	3.93%
Expected life (in years)	4 years 11 months 15 days
Minimum | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	52.68%	51.12%	50.65%
Risk-free interest rate	3.82%	4.30%	1.14%
Expected life (in years)	2 years 5 months 23 days	2 years 2 months 1 day	2 years 25 days
Maximum | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	52.42%
Risk-free interest rate	4.11%
Expected life (in years)	5 years 14 days
Maximum | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	53.19%	56.22%	53.51%
Risk-free interest rate	4.41%	4.36%	3.17%
Expected life (in years)	3 years	3 years	3 years 25 days

Common Stock and Stock-Based _7

Common Stock and Stock-Based Incentive Compensation Plans - Weighted Average Valuation Assumptions for Stock Options (Details) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 28, 2024 USD ($) $ / shares shares
Stock Options
Outstanding Number of Shares
Balance, beginning of period (in shares)	3
Granted (in shares)	0
Exercised (in shares)	(1)
Balance, end of period (in shares)	2
Exercisable, end of period (in shares)	1
Weighted- Average Exercise Price
Balance, beginning of period (USD per share) | $ / shares	$ 68.33
Granted (USD per share) | $ / shares	134.27
Canceled (USD per share) | $ / shares	102.71
Exercised (USD per share) | $ / shares	22.17
Balance, end of period (USD per share) | $ / shares	89.73
Exercisable, end of period (USD per share) | $ / shares	$ 74.61
Aggregate Intrinsic Value
Balance | $	$ 81
Exercisable December 28, 2024 | $	$ 69
Weighted-Average Remaining Contractual Life (in years)
Balance	3 years 11 months 1 day
Exercisable December 28, 2024	2 years 9 months 29 days
Forfeited (in shares)	0
Time Based Restricted Stock Units
Weighted-Average Remaining Contractual Life (in years)
Forfeited (in shares)	(1)

Common Stock and Stock-Based _8

Common Stock and Stock-Based Incentive Compensation Plans - Restricted Stock Units Activates and PRSUs (Details) - $ / shares shares in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Time Based Restricted Stock Units
Number of Shares
Beginning of period (in shares)	32
Granted (in shares)	12
Forfeited (in shares)	(1)
Vested (in shares)	(13)
End of period (in shares)	30	32
Weighted- Average Grant Date Fair Value
Beginning of period, (USD per share)	$ 100.65
Granted (USD per share)	141.95	$ 106.28	$ 92.92
Forfeited (USD per share)	107.96
Vested (USD per share)	101.35
End of period, (USD per share)	$ 116.77	$ 100.65
PRSU
Number of Shares
Beginning of period (in shares)	2
Granted (in shares)	1
Forfeited (in shares)	0
Vested (in shares)	(1)
End of period (in shares)	2	2
Weighted- Average Grant Date Fair Value
Beginning of period, (USD per share)	$ 117.65
Granted (USD per share)	118.98	$ 134.87	$ 121.12
Forfeited (USD per share)	132.80
Vested (USD per share)	91.15
End of period, (USD per share)	$ 139.31	$ 117.65

Common Stock and Stock-Based _9

Common Stock and Stock-Based Incentive Compensation Plans - Weighted Average Valuation Assumptions for PRSUs (Details) - PRSU	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividends	0%	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	52.68%	51.12%	50.65%
Risk-free interest rate	3.82%	4.30%	1.14%
Expected term (in years)	2 years 5 months 23 days	2 years 2 months 1 day	2 years 25 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	53.19%	56.22%	53.51%
Risk-free interest rate	4.41%	4.36%	3.17%
Expected term (in years)	3 years	3 years	3 years 25 days

Common Stock and Stock-Based_10

Common Stock and Stock-Based Incentive Compensation Plans - Weighted Average Valuation Assumptions for ESPP (Details) - ESPP - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividends		0%	0%
Expected term (in years)	6 months	6 months	6 months
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 43
Weighted-average remaining recognition period (in years)	4 months 13 days
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	48.14%	45.74%	58.15%
Risk-free interest rate	4.42%	5.13%	1.43%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	49.38%	49.40%	63.76%
Risk-free interest rate	5.41%	5.46%	4.52%

Retirement Benefit Plans (Detai

Retirement Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Defined Contribution Plan Disclosure [Line Items]
Employer matching contribution, percent of match	75%
Amount of company contributions to the 401(k) plan	$ 78	$ 70	$ 47
Maximum
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	6%

Restructuring and Related Act_3

Restructuring and Related Activities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Restructuring and Related Activities [Abstract]
Payments for Restructuring	$ (24)
Restructuring and Related Cost, Accelerated Depreciation	(73)
Restructuring Reserve	89	$ 0
Severance Costs	186
Restructuring Cost and Reserve [Line Items]
Severance Costs	186
Payments for Restructuring	24
Restructuring Reserve	89	0
Restructuring Reserve, Accrual Adjustment	73
Employee Severance
Restructuring and Related Activities [Abstract]
Payments for Restructuring	(24)
Restructuring and Related Cost, Accelerated Depreciation	0
Restructuring Reserve	89	0
Severance Costs	113
Restructuring Cost and Reserve [Line Items]
Severance Costs	113
Payments for Restructuring	24
Restructuring Reserve	89	0
Restructuring Reserve, Accrual Adjustment	0
Other Restructuring
Restructuring and Related Activities [Abstract]
Payments for Restructuring	0
Restructuring and Related Cost, Accelerated Depreciation	(73)
Restructuring Reserve	0	0
Severance Costs	73
Restructuring Cost and Reserve [Line Items]
Severance Costs	73
Payments for Restructuring	0
Restructuring Reserve	0	$ 0
Restructuring Reserve, Accrual Adjustment	$ 73

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income (Loss) Before Income Tax (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S.	$ 2,369	$ 454	$ 2,093
Non-U.S.	(347)	54	(895)
Income before income taxes and equity income	$ 2,022	$ 508	$ 1,198

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provisions (Benefit) for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Current:
U.S. federal	$ 1,338	$ 496	$ 1,191
U.S. state and local	64	27	31
Non-U.S.	142	150	161
Total	1,544	673	1,383
Deferred:
U.S. federal	(311)	(860)	(1,365)
U.S. state and local	6	(29)	(26)
Non-U.S.	(858)	(130)	(114)
Total	(1,163)	(1,019)	(1,505)
Income tax provision (benefit)	$ 381	$ (346)	$ (122)

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Statutory federal income tax expense at 21%	$ 425	$ 107	$ 252
Tax effect from intercompany integration transaction	373	0	0
Tax effect from intercompany integration transaction [Line Items]
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	(22)	2	3
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	153	(11)	195
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	(232)	(169)	(241)
Effective Income Tax Rate Reconciliation, GILTI, Amount	(133)	(138)	(96)
Effective Income Tax Rate Reconciliation, FDII, Amount	(275)	(185)	(261)
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount	136	53	33
Stock-based and non-deductible compensation	(101)	(17)	(6)
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	13	16	5
Income tax provision (benefit)	$ 381	$ (346)	$ (122)
Effective Income Tax Rate Reconciliation, Percent	19%	68%

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022	Dec. 25, 2021
Income Tax Contingency [Line Items]
Income tax provision (benefit)	$ 381	$ (346)	$ (122)
Unrecognized tax benefits that would impact effective tax rate	1,300	1,300	1,200
Deferred Tax Assets, Valuation Allowance	2,136	2,124	2,078	$ 1,735
Effective Income Tax Rate Reconciliation, FDII, Amount	275	185	261
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	$ 13	$ 16	5
Effective Income Tax Rate Reconciliation, Percent	19%	68%
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	$ 232	$ 169	241
Effective Income Tax Rate Reconciliation, GILTI, Amount	(133)	(138)	(96)
Foreign R&D and investment tax credits	579	597
Accrued Income Taxes, Noncurrent		1,400
Effective Income Tax Rate Reconciliation, FDII, Amount	275	185	261
Stock-based and non-deductible compensation	101	17	$ 6
Accrued Income Taxes, Noncurrent		$ 1,400
Federal
Income Tax Contingency [Line Items]
Tax credit carryforward, amount	12
State/Provincial
Income Tax Contingency [Line Items]
Tax credit carryforward, amount	804
Canada Tax Authority
Income Tax Contingency [Line Items]
Tax credit carryforward, amount	$ 620

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022	Dec. 25, 2021
Deferred tax assets:
Net operating loss carryovers	$ 962	$ 992
Accruals and reserves not currently deductible	829	574
Federal and state tax credit carryovers	679	660
Foreign R&D and investment tax credits	579	597
Deferred Tax Assets, Tax Credit Carryforwards, Foreign	77	71
Lease liability	182	181
Other	111	96
Total deferred tax assets	6,645	5,226
Less: valuation allowance	(2,136)	(2,124)	$ (2,078)	$ (1,735)
Total deferred tax assets, net of valuation allowance	4,509	3,102
Deferred tax liabilities:
Right-of-use assets	(182)	(175)
Acquired intangibles	(3,614)	(3,104)
Deferred Tax Liabilities, GILTI	(222)	(524)
Other	(152)	(135)
Total deferred tax liabilities	(4,170)	(3,938)
Deferred Tax Assets (Liabilities), Noncurrent, Net	339	(836)
Deferred Tax Asset, In-Process Research and Development	2,892	1,753
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits	$ 334	$ 302

Income Taxes - Movement in Defe

Income Taxes - Movement in Deferred Tax Valuation Allowance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Valuation Allowance [Line Items]
Beginning balance	$ 2,124	$ 2,078	$ 1,735
Ending balance	2,136	2,124	2,078
Charged (reductions) to expense/other accounts
Valuation Allowance [Line Items]
Increase (decrease) in valuation allowance	9	41	112
Acquisition-related Costs
Valuation Allowance [Line Items]
Increase (decrease) in valuation allowance	$ 3	$ 5	$ 231

Income Taxes - Schedule of De_2

Income Taxes - Schedule of Deferred Tax Assets and Liabilities, Current and Noncurrent (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Income Tax Disclosure [Abstract]
Deferred Tax Assets (Liabilities), Noncurrent, Net	$ 339	$ (836)
Deferred tax assets, net	$ 688	$ 366

Income Taxes - Summary of Tax A

Income Taxes - Summary of Tax Attribute Carryforwards (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Tax Attribute Carryforwards [Line Items]
Foreign R&D and investment tax credits	$ 579	$ 597
Federal and state tax credit carryovers	679	660
Federal and state tax credit carryovers	679	$ 660
Federal
Tax Attribute Carryforwards [Line Items]
Operating loss carryforwards, amount	134
Tax credit carryforward, amount	12
State/Provincial
Tax Attribute Carryforwards [Line Items]
Operating loss carryforwards, amount	362
Tax credit carryforward, amount	804
Canada Tax Authority
Tax Attribute Carryforwards [Line Items]
Tax credit carryforward, amount	$ 620

Income Taxes - Schedule of Gros

Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]
Balance at beginning of year	$ 1,463	$ 1,361	$ 275
Increases for tax positions taken in prior years	24	57	104
Decreases for tax positions taken in prior years	(18)	(8)	(12)
Unrecognized Tax Benefits, Increase Resulting from Acquisition	0	0	252
Increases for tax positions taken in the current year	57	53	748
Decreases for settlements with taxing authorities and statute of limitation lapses	(28)	0	(6)
Balance at end of year	1,498	1,463	1,361
Unrecognized Tax Benefits, Income Tax Penalties Expense	$ 298	$ 142	$ 81

Other Expense, Net (Details)

Other Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Income Statement Related Disclosures [Abstract]
Interest income	$ 182	$ 206	$ 65
Gains (losses) on equity investments, net	2	(1)	(62)
Other income (expense)	(3)	(8)	5
Other income (expense), net	$ 181	$ 197	$ 8

Commitments and Guarantees - Su

Commitments and Guarantees - Supplemental Information Related to Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Variable lease, cost	$ 83	$ 46	$ 40
Weighted-average remaining lease term in years – operating leases	7 years 3 months 10 days
Weighted-average discount rate – operating leases	4.63%
Operating Lease, Cost	$ 147	$ 127	$ 118

Commitments and Guarantees - Op

Commitments and Guarantees - Operating Lease Obligations (Details) - USD ($) $ in Millions	Dec. 28, 2024	Dec. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
2021	$ 134
2022	135
2023	94
2024	66
2025	60
2026 and thereafter	235
Total minimum lease payments	724
Less: interest	(124)
Present value of net minimum lease payments	600
Operating Lease, Liability, Current	$ (109)
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other current liabilities
Total long-term operating lease liabilities	$ 491	$ 535

Commitments and Guarantees - Na

Commitments and Guarantees - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Long-term Purchase Commitment [Line Items]
Variable lease, cost	$ 83	$ 46	$ 40
Operating Lease, Payments, Use	155	147	108
Operating Lease, Cost	$ 147	$ 127	$ 118

Commitments and Guarantees - Un

Commitments and Guarantees - Unconditional Purchase Obligations (Details) $ in Millions	Dec. 28, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2025	$ 4,501
2026	274
2027	46
2028	46
2029	45
2030 and thereafter	56
Total unconditional purchase commitments	$ 4,968

Commitments and Guarantees - Sc

Commitments and Guarantees - Schedule of Changes in Product Warranty Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Changes in Product Warranty Liability [Roll Forward]
Beginning balance	$ 85	$ 65
Provisions during the period	213	126
Settlements during the period	(110)	(106)
Ending balance	$ 188	$ 85